Other disorders of fluid, electrolyte and acid-base balance

E4_FLUIDELECTRO

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — E87 Cause of death: ICD-10 — E87 2 out of 7 registries used, show all original rules.	18236
4. Check minimum number of events None	18236
5. Include endpoints E4_HYPEROSMHNAT E4_HYPOOSMNAT E4_ACIDOSIS E4_ALKALOSIS E4_MIXACIDBASE E4_HYPERKALAEMIA E4_HYPOKALAEMIA E4_FLUIDOVER E4_FLUIDELECTRONAS	18490
6. Filter based on genotype QC (FinnGen only)	16395

Control definitions (FinnGen only)

Control exclude: E4_METABOLIA

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: E70-E90
Name in latin: Aliae perturbationes aequilibrii humoralis, electrolytici et acido-alkalici

NAME	E4_FLUIDELECTRO
CONTROL_EXCLUDE	E4_METABOLIA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	E4_HYPEROSMHNAT\|E4_HYPOOSMNAT\|E4_ACIDOSIS\|E4_ALKALOSIS\|E4_MIXACIDBASE\|E4_HYPERKALAEMIA\|E4_HYPOKALAEMIA\|E4_FLUIDOVER\|E4_FLUIDELECTRONAS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	E87
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	E87
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other disorders of fluid, electrolyte and acid-base balance based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	135674	82514	52202
Only index persons	114174	70187	43987
Unadjusted period prevalence (%)
Whole population	2.01	2.36	1.46
Only index persons	2.23	2.58	1.68
Median age at first event (years)
Whole population	72.18	75.73	66.59
Only index persons	72.02	75.45	66.55

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	16395	9064	7331
Unadjusted period prevalence (%)	3.28	3.22	3.36
Median age at first event (years)	70.02	70.31	69.65

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
16836: Matched controls
158501

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.0

322.7

4854

26711

N03AX14

ATC

levetiracetam; systemic

4.6

322.4

810

1726

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

2.1

318.8

4137

21573

N03AX16

ATC

[U] pregabalin

2.0

318.5

4304

22779

A10AC01

ATC

insulin (human); parenteral

2.9

317.0

1606

5476

T90

ICPC

Diabetes non-insulin dependent

2.0

316.5

4617

25106

C01DA14

ATC

isosorbide mononitrate; oral

2.2

315.8

3265

15593

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

6.4

312.8

540

817

R60.0

ICD-10 Finland

Localized oedema

2.3

311.9

2823

12755

N06AB04

ATC

citalopram; systemic

2.1

310.9

3890

19987

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.9

309.4

1627

5659

N30.0

ICD-10 Finland

Acute cystitis

2.2

307.7

3458

16479

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

7.4

307.7

545

715

A11CC03

ATC

alfacalcidol; systemic

6.8

307.7

716

1024

L28

ICPC

Limited function/disability (L)

2.5

307.7

4527

20656

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

10.4

307.7

468

435

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.7

307.7

3703

14953

V03AE01

ATC

polystyrene sulfonate; oral

9.7

307.7

576

575

N05AH03

ATC

olanzapine; systemic

3.5

307.7

1387

3998

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

9.7

307.7

405

401

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.0

307.7

3336

12139

N05CF01

ATC

zopiclone; oral

2.1

307.7

6644

37289

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

4.2

307.7

2111

5176

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.6

307.7

1584

4444

C03DA01

ATC

spironolactone; oral

4.1

307.7

4156

11807

F10.20

ICD-10 Finland

Alcohol dependence currently independent

6.6

307.7

649

950

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

12.9

307.7

615

465

C02AC05

ATC

moxonidine; oral

4.0

307.7

1276

3207

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.8

307.7

3858

15370

P15

ICPC

Chronic alcohol abuse

5.9

307.7

891

1497

N18.8

ICD-10 Finland

Other chronic renal failure

5.6

307.7

774

1349

TK800

NOMESCO Finland

Hemodialysis

7.1

307.7

720

996

WX892

NOMESCO Finland

Monitored bed care

3.5

307.7

1940

5739

F10.25

ICD-10 Finland

Alcohol dependence continuous use

9.0

307.7

715

778

A02BC02

ATC

pantoprazole; systemic

2.2

307.7

12358

87683

A10AB05

ATC

insulin aspart; parenteral

3.8

307.7

1919

5145

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

3.8

307.7

1412

3752

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.1

307.7

4673

24056

N05BA01

ATC

diazepam; systemic, rectal

2.4

307.7

2776

11836

A10AE04

ATC

insulin glargine; parenteral

3.3

307.7

2293

7152

N05AH04

ATC

quetiapine; oral

2.8

307.7

3665

14479

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.7

307.7

2077

7978

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.3

307.7

4817

23962

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.5

307.7

3139

9719

XF400

NOMESCO Finland

ECG with 12 standard connections

2.3

307.7

3167

14606

N05BA04

ATC

oxazepam; oral

2.3

307.7

5443

27037

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

5.1

307.7

735

1409

I50.0

ICD-10 Finland

Congestive heart failure

3.1

307.7

2245

7468

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.1

307.7

7114

41374

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

5.9

307.7

2368

4282

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

3.0

307.7

2538

8961

E87.5

ICD-10 Finland

Hyperkalaemia

93.2

307.7

2719

327

TPH04

NOMESCO Finland

Cathetrisation of vein

2.4

307.7

4680

21688

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.4

307.7

3106

13423

C07AB07

ATC

bisoprolol; oral

2.5

307.7

10293

60663

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

6.5

307.7

718

1074

SPAT1262

SPAT

Handing over of treatment supplies

2.3

307.7

3578

16725

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

8.9

307.7

524

567

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.3

307.7

5102

25054

C03CA01

ATC

furosemide; systemic

3.6

307.7

8945

38092

R06.0

ICD-10 Finland

Dyspnoea

2.2

307.7

5483

29064

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.9

307.7

10439

57460

F10.24

ICD-10 Finland

Alcohol depence active use

9.3

307.7

564

588

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.7

307.7

6495

30278

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.9

307.7

1954

6931

I25.1

ICD-10 Finland

Atherosclerotic heart disease

2.2

307.7

4484

22716

N17.9

ICD-10 Finland

Acute renal failure, unspecified

7.9

307.7

2016

2670

R56.8

ICD-10 Finland

Other and unspecified convulsions

5.0

307.7

1564

3157

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.7

307.7

4908

15813

E86

ICD-10 Finland

Volume depletion

66.2

307.7

1154

176

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

6.2

307.7

1642

2715

A06AD11

ATC

lactulose; oral

2.6

307.7

3798

16077

E87.6

ICD-10 Finland

Hypokalaemia

126.2

307.7

5746

648

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

7.1

307.7

793

1098

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

10.5

307.7

493

454

C08CA01

ATC

amlodipine; oral

2.6

307.7

8757

46518

N19

ICD-10 Finland

Unspecified kidney failure

4.3

307.7

1117

2582

G40.9

ICD-10 Finland

Epilepsy, unspecified

4.5

307.7

948

2063

E83.51

ICD-10 Finland

Hypocalcemia

43.4

307.7

272

R11

ICD-10 Finland

Nausea and vomiting

3.9

307.7

2519

6769

R53

ICD-10 Finland

Malaise and fatigue

2.9

307.7

5996

25046

C08CA13

ATC

lercanidipine; oral

2.3

307.7

3250

14788

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

3.0

307.7

3621

13262

H02AB09

ATC

hydrocortisone; systemic

6.3

307.7

738

1146

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.5

307.7

6470

32004

N07BB01

ATC

disulfiram; oral

4.5

307.7

1037

2276

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.3

307.7

7011

37396

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

4.0

307.7

6144

19765

I50.9

ICD-10 Finland

Heart failure, unspecified

3.2

307.7

4429

15827

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

307.4

307.7

568

ZXD05

NOMESCO Finland

Urgent procedure

2.1

307.7

5474

29709

205

Kela drug reimbursment

Chronic hypertension

2.3

307.7

6098

31410

AA1AD

NOMESCO Finland

CT of head and brain

3.3

307.7

7620

31624

I10

ICD-10 Finland

Essential (primary) hypertension

2.7

307.7

12397

80468

C10AA01

ATC

simvastatin; oral

1.9

307.7

7571

47709

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

337.4

307.7

8744

506

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

3.5

307.7

1302

3690

N06AX11

ATC

mirtazapine; oral

2.2

307.7

6699

36264

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.8

307.7

2333

8644

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

3.0

307.7

3605

13401

N03AG01

ATC

valproic acid; systemic, rectal

3.5

307.7

1386

3964

E87.2

ICD-10 Finland

Acidosis

1985.1

307.7

841

N02AA05

ATC

oxycodone; systemic

2.4

307.7

4482

20933

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.5

307.7

3713

16166

JN3AD

NOMESCO Finland

Abdominal CT examination

2.8

307.7

3163

12083

A04

ICPC

Weakness/tiredness general

2.3

307.7

3305

14928

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.4

307.7

3540

16077

SPAT1254

SPAT

Administration of medicine

2.5

307.7

3445

14737

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

6.8

307.7

849

1225

A28

ICPC

Limited function/disability NOS

2.7

307.7

4784

20041

N17.8

ICD-10 Finland

Other acute renal failure

8.3

307.7

482

559

T36

ICD-10 Finland

Poisoning by systemic antibiotics

4.9

307.7

1031

2063

D64.9

ICD-10 Finland

Anaemia, unspecified

3.2

307.7

3218

10805

103

Kela drug reimbursment

Diabetes, insulin-treated

2.2

307.7

5461

28646

E87.8

ICD-10 Finland

Other disorders of electrolyte and fluid balance, not elsewhere classified

82.5

307.7

293

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.3

307.7

3262

10785

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

11.7

307.7

374

308

TPH07

NOMESCO Finland

Cathetrisation of artery

2.8

307.7

2628

9740

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.5

307.7

1650

4759

JN4AD

NOMESCO Finland

Body CT examination

2.4

307.7

2713

11594

B01AC04

ATC

clopidogrel; oral

2.4

307.7

3161

13991

C09AA05

ATC

ramipril; oral

2.0

307.5

4924

27607

J01MA02

ATC

ciprofloxacin; systemic

1.8

306.6

7228

45914

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

3.0

305.8

1509

5066

Z49.1

ICD-10 Finland

Extracorporeal dialysis

7.7

304.9

441

549

S97

ICPC

Chronic ulcer skin

2.9

302.5

1591

5532

R55

ICD-10 Finland

Syncope and collapse

2.4

301.9

2476

10708

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

6.3

301.4

531

820

A46

ICD-10 Finland

Erysipelas

2.2

299.9

3174

15269

F10.09

ICD-10 Finland

Alcohol intoxication UNS

5.9

298.6

564

933

R41.0

ICD-10 Finland

Disorientation, unspecified

3.8

296.6

948

2420

A12AA04

ATC

calcium carbonate; oral

7.0

295.1

466

641

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

2.1

292.0

3307

16317

B03XA02

ATC

darbepoetin alfa; parenteral

5.2

290.5

622

1156

A10AE05

ATC

insulin detemir; parenteral

3.5

290.0

1097

3136

N05AA02

ATC

levomepromazine; systemic

3.7

289.3

973

2573

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

5.1

288.9

630

1190

TKC20

NOMESCO Finland

Catheterisation of bladder

2.8

287.6

1609

5777

A12BA01

ATC

potassium chloride; oral

3.2

287.5

1232

3806

N05CD07

ATC

temazepam; oral

2.3

282.4

2667

12225

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.1

281.8

3446

17477

A41.9

ICD-10 Finland

Sepsis, unspecified

3.6

281.5

993

2711

C07AB02

ATC

metoprolol; systemic

2.0

279.0

4084

22083

A10BA02

ATC

metformin; oral

1.9

278.2

5204

30521

R42

ICD-10 Finland

Dizziness and giddiness

1.9

277.4

4526

25384

N02AX02

ATC

tramadol; systemic, rectal

1.8

276.5

7631

50334

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.8

275.5

6103

37698

127

Kela drug reimbursment

Transplant complication

6.9

275.4

438

607

R33

ICD-10 Finland

Retention of urine

2.5

274.5

1902

7593

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.3

274.3

1093

3227

N05AX08

ATC

risperidone; systemic

2.5

274.1

1969

7996

J01MA12

ATC

levofloxacin; systemic

2.0

273.9

3664

19177

UJF32

NOMESCO Finland

Coloscopy

1.9

273.1

4999

29081

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

5.9

272.7

508

829

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.5

272.3

1915

7698

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.8

270.6

1486

5277

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.5

270.6

991

2772

M04AA01

ATC

allopurinol; systemic

2.2

270.5

2764

13062

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.1

265.5

1203

3837

F05.9

ICD-10 Finland

Delirium, unspecified

4.5

264.3

682

1482

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.9

263.8

4593

26240

R50.9

ICD-10 Finland

Fever, unspecified

2.1

263.2

2901

14109

N02BE01

ATC

paracetamol; systemic, rectal

2.4

261.4

15058

123700

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.4

261.1

2000

8354

G72.8

ICD-10 Finland

Other specified myopathies

5.4

259.5

534

957

Z94.0

ICD-10 Finland

Kidney transplant status

8.4

259.0

350

401

R07.4

ICD-10 Finland

Chest pain, unspecified

1.8

257.8

4969

29281

T89

ICPC

Diabetes insulin dependent

4.0

256.4

768

1869

C03AA03

ATC

hydrochlorothiazide; oral

2.4

256.2

2012

8496

SPAT1263

SPAT

Sampling

1.8

256.0

7154

47027

SPAT1216

SPAT

Assessment of functional ability

2.0

255.7

3317

17120

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

12.1

255.4

265

209

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.4

254.4

994

2896

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.1

254.0

3021

15102

H02AB06

ATC

prednisolone; systemic

1.7

252.6

8331

57290

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.8

252.2

5024

29868

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.0

252.1

3311

17155

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.3

252.0

2089

9029

L04AD02

ATC

tacrolimus; systemic

9.3

252.0

314

324

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

4.7

250.6

601

1230

P16

ICPC

Acute alcohol abuse

6.3

250.0

437

669

N03AF02

ATC

oxcarbazepine; oral

3.9

247.9

770

1923

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

4.0

246.1

729

1759

SPAT1301

SPAT

No procedures

1.8

245.3

5699

35413

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

8.7

244.6

320

352

SPAT1229

SPAT

Assessment of need for aid

2.5

243.3

1776

7245

J01DB01

ATC

cefalexin; oral

1.9

243.1

13588

108183

C09AA02

ATC

enalapril; systemic

1.9

242.9

3866

21360

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

9.7

240.6

290

286

E22.2

ICD-10 Finland

Syndrome of inappropriate secretion of antidiuretic hormone

44.2

239.5

149

N06AX16

ATC

venlafaxine; oral

2.2

239.3

2270

10372

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.3

239.3

2056

9014

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

6.8

238.9

385

541

EBA15

NOMESCO Finland

Extraction of multiple teeth

3.3

237.3

958

2847

WX872

NOMESCO Finland

Intensive care

3.1

234.9

1071

3423

A03FA01

ATC

metoclopramide; systemic, rectal

1.9

234.9

4081

23161

ZX120

NOMESCO Finland

Intravenous

2.4

234.2

1842

7766

K70.1

ICD-10 Finland

Alcoholic hepatitis

11.2

233.4

255

218

AN1

Coronary angiography

2.3

232.6

1996

8739

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

7.8

230.6

331

408

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.4

230.3

1814

7651

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

11.1

229.6

252

217

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

8.4

228.4

308

352

S06.0

ICD-10 Finland

Concussion

2.3

228.1

2060

9211

Z51.5

ICD-10 Finland

Palliative care

2.2

225.5

2061

9259

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.5

223.4

1572

6294

K59.09

ICD-10 Finland

Constipation, unspecified

2.5

221.3

1508

5947

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

4.5

221.1

558

1190

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

6.5

220.8

373

551

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

9.2

220.2

276

287

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.2

219.5

2178

10109

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.4

218.9

1607

6559

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

4.8

217.6

511

1027

L04AA06

ATC

mycophenolic acid; systemic

5.1

217.5

473

890

A10BH05

ATC

linagliptin; oral

2.8

216.1

1141

3954

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

3.5

215.0

791

2214

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.9

214.9

3726

21047

N06AX21

ATC

duloxetine; oral

2.2

214.5

2058

9420

C10AA05

ATC

atorvastatin; oral

1.7

212.6

6960

47030

137

Kela drug reimbursment

Uraemia requiring dialysis

8.8

212.0

275

299

N03AX09

ATC

lamotrigine; oral

3.4

211.4

803

2294

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

3.7

210.9

707

1860

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

9.9

209.8

248

238

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

9.6

208.4

253

252

J01FF01

ATC

clindamycin; systemic

1.8

207.9

4540

27443

WX882

NOMESCO Finland

High dependency care

3.7

207.7

686

1786

X59

ICD-10 Finland

Exposure to unspecified factor

1.9

207.3

3295

18077

N05BA06

ATC

lorazepam; systemic, sublingual

2.7

207.0

1187

4294

R63.1

ICD-10 Finland

Polydipsia

20.7

206.8

163

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.2

205.2

1916

8665

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.9

205.0

1057

3614

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.8

204.3

1140

4065

C08CA02

ATC

felodipine; oral

2.2

203.3

2009

9293

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

11.7

201.5

213

173

A10BH01

ATC

sitagliptin; oral

2.3

201.0

1796

7973

Z2446

NOMESCO Finland

Social worker

2.7

200.9

1167

4248

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.5

200.2

1434

5778

N03AX12

ATC

[U] gabapentin; oral

2.0

200.0

2784

14599

SPAT1234

SPAT

Support of social functional capacity

2.6

199.7

1227

4594

E0000UV, ,

ATC

1.6

198.3

6867

46820

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.0

198.2

2703

14071

B05DA

ATC

Isotonic solutions

9.7

198.1

239

236

N05AF03

ATC

chlorprothixene; systemic

4.0

197.8

579

1383

TPX10

NOMESCO Finland

Implantation of vascular injection port

3.6

196.7

691

1875

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.1

196.6

2287

11249

R02

ICPC

Shortness of breath/dyspnoea

2.0

196.3

2530

12911

Z3231

NOMESCO Finland

Registered nurse

1.7

195.2

4524

27724

W19

ICD-10 Finland

Unspecified fall

2.2

195.1

1981

9253

I95.1

ICD-10 Finland

Orthostatic hypotension

2.9

194.6

957

3186

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.7

193.7

656

1737

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

5.9

192.3

358

583

B01AA03

ATC

warfarin; systemic

1.8

191.5

3748

21862

B01AB05

ATC

enoxaparin; parenteral

1.7

191.0

5479

35517

B05DB

ATC

Hypertonic solutions

10.0

189.3

223

213

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.7

188.8

5031

31966

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.9

188.6

3117

17257

N06AB10

ATC

escitalopram; oral

1.9

188.1

2971

16211

A10AB01

ATC

insulin (human); parenteral

3.6

187.2

638

1696

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.1

186.8

808

2498

WW500

NOMESCO Finland

Blood transfusion

2.9

186.1

913

3034

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.5

185.9

1287

5099

Z49.2

ICD-10 Finland

Other dialysis

9.4

185.6

229

233

E83.50

ICD-10 Finland

Hypercalcemia

8.0

184.7

257

305

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.3

183.8

1521

6526

J01EA01

ATC

trimethoprim; systemic

1.7

183.5

4499

27915

E27.1

ICD-10 Finland

Primary adrenocortical insufficiency

19.1

183.0

149

N30.9

ICD-10 Finland

Cystitis, unspecified

2.4

182.7

1369

5622

K92.1

ICD-10 Finland

Melaena

2.6

181.9

1189

4583

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

5.3

181.4

375

674

207

Kela drug reimbursment

Chronic arrhythmias

1.8

180.8

3202

18084

C09CA01

ATC

losartan; oral

1.7

180.4

4645

29177

N05BA02

ATC

chlordiazepoxide; systemic

3.8

178.9

565

1425

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.1

178.0

1831

8578

S01.0

ICD-10 Finland

Open wound of scalp

2.2

177.8

1640

7358

R4110

NOMESCO Finland

Physiotherapy

1.7

177.7

4475

27922

A29

ICPC

General symptom/complaint other

1.9

177.3

2551

13476

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

7.2

176.8

272

363

C07AG02

ATC

carvedilol; oral

2.5

176.5

1220

4826

R03BB04

ATC

tiotropium bromide; inhalant

2.1

175.6

2019

9860

WZC00

NOMESCO Finland

Treatment plan or consultation

1.6

175.2

5975

40240

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.0

174.9

819

2650

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.2

174.7

1718

7905

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.2

174.3

1592

7112

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.6

174.1

6466

44428

WX730

NOMESCO Finland

Conventional respirator

4.7

173.1

419

863

F29

ICD-10 Finland

Unspecified nonorganic psychosis

3.6

172.1

603

1632

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

171.6

4131

25427

N03AF01

ATC

carbamazepine; oral, rectal

2.6

171.3

1029

3802

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

11.8

171.1

180

145

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

5.0

170.7

376

715

A06AC01

ATC

ispaghula (psylla seeds); oral

1.7

170.5

4599

29161

Z49.0

ICD-10 Finland

Preparatory care for dialysis

7.1

170.4

264

355

R60.9

ICD-10 Finland

Oedema, unspecified

2.5

169.8

1190

4736

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.8

167.7

3263

18903

A10AB04

ATC

insulin lispro; parenteral

3.8

167.0

525

1319

N06AB06

ATC

sertraline; oral

2.1

166.9

1746

8222

N18.0

ICD-10 Finland

End-stage renal disease

6.2

166.6

295

457

J01CA08

ATC

pivmecillinam; oral

1.6

166.6

6300

43346

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

2.5

166.5

1155

4573

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.7

166.4

977

3568

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

3.0

165.8

788

2570

R51.80

ICD-10 Finland

Headache

1.9

165.8

2300

11982

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

9.0

165.7

211

224

A10BB12

ATC

glimepiride; oral

2.3

165.3

1364

5835

V03AE02

ATC

sevelamer; oral

10.5

165.1

188

171

B01AF02

ATC

apixaban; oral

1.9

164.4

2647

14472

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

9.7

164.2

197

193

XF600

NOMESCO Finland

Bloodpressure measurement

2.4

163.7

1190

4814

J45.9

ICD-10 Finland

Asthma, unspecified

1.8

163.2

3198

18548

F20.9

ICD-10 Finland

Schizophrenia, unspecified

4.3

160.9

434

974

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

3.6

159.9

556

1497

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.2

159.5

1557

7132

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.3

158.1

1246

5222

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.8

158.0

3176

18535

I50

ICD-10 Finland

Heart failure

2.9

157.9

775

2573

A02BC01

ATC

omeprazole; systemic

1.6

157.8

4643

29985

K92.0

ICD-10 Finland

Haematemesis

3.4

157.4

587

1654

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.4

157.3

1146

4638

M10.9

ICD-10 Finland

Gout, unspecified

2.3

157.1

1343

5827

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

8.9

156.7

200

213

SPAT1255

SPAT

Intravenous administration of medicine

2.3

156.4

1305

5604

TK810

NOMESCO Finland

Hemofiltration

9.1

155.9

197

207

E26.0

ICD-10 Finland

Primary hyperaldosteronism

8.3

155.6

210

240

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

155.6

6358

44338

K70.0

ICD-10 Finland

Alcoholic fatty liver

6.8

155.1

251

354

SPAT1260

SPAT

Consultation of another employee

1.8

153.6

3042

17662

A01

ICPC

Pain general/multiple sites

2.0

152.4

1812

8932

196

Kela drug reimbursment

Paricalcitol and cinacalcet

11.1

151.8

166

142

I20.09

ICD-10 Finland

Unstable angina

2.5

151.8

1017

3958

ZXE20

NOMESCO Finland

More than three and less than five hours

1.9

151.5

2244

11920

P29

ICPC

Psychological sympt/compl other

2.5

151.4

1011

3928

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

150.6

1833

9108

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.8

150.5

2942

17007

SPAT1167

SPAT

Insertion of urinary catheter

2.9

149.3

750

2521

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.7

149.1

858

3098

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.8

149.1

470

1183

Z72.1

ICD-10 Finland

Alcohol use

5.3

148.9

306

547

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.7

148.6

881

3229

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

2.9

148.5

733

2440

N05AX12

ATC

aripiprazole; systemic

3.3

147.6

577

1675

E83.4

ICD-10 Finland

Disorders of magnesium metabolism

244.3

146.9

154

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.8

146.6

2635

14851

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

4.4

146.2

385

848

WZC30

NOMESCO Finland

Teaching

1.8

145.7

2790

16016

B03BA03

ATC

hydroxocobalamin; parenteral

2.3

145.3

1179

4999

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.8

145.2

762

2622

A07AA09

ATC

vancomycin; oral

4.4

145.1

376

818

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

7.9

145.0

205

248

H3603, E103,

ICD-10 Finland

8.0

144.8

201

238

R18

ICD-10 Finland

Ascites

3.6

144.5

500

1341

A02BC05

ATC

esomeprazole; systemic

1.5

144.4

6479

45906

N03AX18

ATC

lacosamide; systemic

7.0

144.1

227

311

R4190

NOMESCO Finland

Nutritional therapy

3.0

144.0

686

2238

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

3.0

143.6

659

2105

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.8

143.2

2311

12598

UKC02

NOMESCO Finland

Cystoscopy

1.7

143.1

2955

17323

R5110, ,

SPAT

2.0

143.0

1655

8069

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.7

143.0

2969

17430

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

2.4

142.9

1076

4415

I25.2

ICD-10 Finland

Old myocardial infarction

2.3

142.4

1161

4931

KA1AE

NOMESCO Finland

Kidney ultrasound examination

3.4

142.4

539

1533

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.2

141.7

579

1727

N06AA09

ATC

amitriptyline; systemic

2.0

141.4

1704

8427

I95.9

ICD-10 Finland

Hypotension, unspecified

4.2

141.0

383

864

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.1

141.0

623

1947

I50.1

ICD-10 Finland

Left ventricular failure

2.4

140.9

1046

4264

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.8

140.6

741

2555

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

3.5

140.0

493

1338

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.9

140.0

1920

9927

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

2.0

139.7

1627

7948

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

6.5

139.5

234

343

K08.3

ICD-10 Finland

Retained dental root

2.1

138.3

1448

6800

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.9

138.0

680

2260

L89

ICD-10 Finland

Decubitus ulcer and pressure area

3.5

137.4

494

1359

E87

ICD-10 Finland

Other disorders of fluid, electrolyte and acid-base balance

58.2

135.5

SPAT1240

SPAT

Therapeutic discussion

2.1

135.1

1389

6475

A10AE06

ATC

insulin degludec; parenteral

3.1

134.2

576

1769

C07AA05

ATC

propranolol; systemic

1.7

134.2

2920

17333

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

9.7

134.0

161

158

A10AA01, ,

ATC

3.8

133.8

422

1062

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

133.7

3627

22800

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.8

133.5

2224

12221

K70.4

ICD-10 Finland

Alcoholic hepatic failure

9.4

133.5

164

166

K59.1

ICD-10 Finland

Functional diarrhoea

2.4

133.0

1028

4264

J01MA14

ATC

moxifloxacin; systemic

2.0

132.1

1572

7731

H03AA01

ATC

levothyroxine sodium; systemic

1.6

131.6

3593

22609

N05AH02

ATC

clozapine; systemic

4.6

131.5

323

673

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

131.3

5586

38911

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

2.6

131.3

839

3188

Z02.7

ICD-10 Finland

Issue of medical certificate

2.1

131.1

1293

5929

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.6

130.9

4786

32251

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

4.2

130.4

359

818

WX002

NOMESCO Finland

Sedation and analgesia

1.7

130.2

3130

19063

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.4

130.0

939

3778

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

12.9

129.5

129

SPAT1265

SPAT

Breathalyser

6.3

129.4

222

333

A08

ICPC

Swelling

2.2

129.0

1133

4960

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

2.2

128.9

1191

5321

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

8.7

128.8

168

184

H04AA01

ATC

glucagon; nasal, parenteral

4.3

128.6

340

751

K07

ICPC

Swollen ankles/oedema

2.3

128.2

1024

4306

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

3.6

127.2

438

1171

SPAT1125

SPAT

Stoma care and guidance

3.6

126.4

436

1167

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

3.8

126.0

405

1033

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

7.4

125.8

187

240

XF404

NOMESCO Finland

Ambulatory ECG

2.0

125.8

1466

7151

N06AB03

ATC

fluoxetine; oral

1.9

125.4

1888

10040

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

3.7

125.4

420

1102

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.1

125.1

1294

6040

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.0

125.0

1407

6777

ZY010

NOMESCO Finland

Hospital outpatient

2.6

124.9

739

2703

E23.00

ICD-10 Finland

Panhypopituitarism

10.5

124.6

141

127

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

6.0

124.2

227

363

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

3.6

123.6

430

1157

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.7

123.5

2750

16386

SPAT1252

SPAT

Overall medication plan or its review

2.1

123.3

1310

6176

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

6.2

123.0

216

332

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

4.9

122.8

281

552

XCK10

NOMESCO Finland

Photography of fundus of eye

1.9

122.7

1609

8175

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.4

122.6

934

3846

C09BA02

ATC

enalapril and diuretics; systemic

2.0

122.1

1490

7385

JN4BD

NOMESCO Finland

Extensive body CT

1.8

122.0

1893

10159

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

3.6

121.7

424

1142

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

121.6

6045

43312

Z3226

NOMESCO Finland

Physiotherapist

1.7

121.6

2736

16341

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

11.0

121.6

134

116

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.6

120.9

722

2652

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

12.4

120.8

123

GD1AD

NOMESCO Finland

Thorax CT examination

2.1

120.5

1215

5614

TK820

NOMESCO Finland

Peritoneal dialysis

9.7

120.0

144

141

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

120.0

7653

57537

F10.41

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol with seizures

12.6

120.0

121

N18.4

ICD-10 Finland

Chronic kidney disease, stage 4

5.3

119.8

250

453

3025

Kela drug reimbursment

Calcium carbonate

8.7

119.5

156

171

E87.7

ICD-10 Finland

Fluid overload

296.6

119.5

124

F10.03

ICD-10 Finland

Alcohol-related acute intoxication with delirium

9.6

119.4

144

142

SPAT1100

SPAT

Long-term monitoring of blood pressure

2.1

119.3

1300

6184

Z71.8

ICD-10 Finland

Other specified counselling

1.5

119.1

4821

33073

N02BF02

ATC

pregabalin; oral

2.2

118.4

1129

5104

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

3.9

118.2

357

871

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

118.2

6671

48933

R03AC02

ATC

salbutamol; inhalant

1.5

118.2

8163

62242

N06AX03

ATC

mianserin; oral

2.4

118.1

880

3587

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

5.1

118.1

256

480

S18

ICPC

Laceration/cut

1.5

117.9

7662

57741

OAB43, ,

SPAT

0.5

117.1

1005

18867

C09CA03

ATC

valsartan; oral

1.9

116.4

1649

8589

M05BX04

ATC

denosumab; parenteral

2.1

116.2

1281

6117

B01AB10

ATC

tinzaparin; parenteral

1.8

116.2

1834

9886

NF1AA

NOMESCO Finland

Hip X-ray examination

1.8

115.8

1811

9734

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.2

115.7

479

1439

N05BE01

ATC

buspirone; oral

3.0

115.7

534

1710

A41.8

ICD-10 Finland

Other specified sepsis

3.4

115.6

432

1218

ZXE00

NOMESCO Finland

One hour or less

1.5

115.5

5788

41423

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

115.0

10617

85323

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

3.8

114.4

362

913

S42.2

ICD-10 Finland

Fracture of upper end of humerus

2.3

113.9

973

4205

SPAT1310

SPAT

Counselling related to known health issue

1.5

113.4

4906

34055

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

113.0

4113

27517

N04AA02

ATC

biperiden; systemic

3.6

113.0

393

1057

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

8.8

113.0

146

158

K77

ICPC

Heart failure

2.9

112.8

542

1775

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.0

112.8

1318

6426

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.8

112.4

2061

11610

E66.00

ICD-10 Finland

Metabolic syndrome

2.4

112.1

788

3128

2768A

ICD-9 Finland

Disorders of fluid, electrolyte and acid-base balance, Hypopotassaemia[HYPOKALAEMIA]

+∞

112.1

110

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

2.5

111.9

750

2912

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.9

111.7

1440

7264

N03AE01

ATC

clonazepam; systemic

2.2

111.3

984

4312

A10AA02, ,

ATC

2.8

110.6

562

1898

M54.5

ICD-10 Finland

Low back pain

1.5

110.3

5333

37814

N06AA12

ATC

doxepin; systemic

2.2

110.0

939

4056

N05BA12

ATC

alprazolam; oral

1.9

109.9

1575

8227

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.7

109.8

2289

13363

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.0

109.5

1349

6697

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.3

109.5

926

3984

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

2.1

109.4

1072

4893

P99

ICPC

Psychological disorders other

3.2

109.3

461

1400

105

Kela drug reimbursment

Adrenal cortical hypofunction

14.4

109.2

102

V03AA01, ,

ATC

3.9

108.9

333

820

H3600, E103,

ICD-10 Finland

6.5

108.8

183

269

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.2

108.8

935

4050

A02BC03

ATC

lansoprazole; oral

1.5

108.8

4592

31659

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

3.4

108.6

401

1122

H02AA02

ATC

fludrocortisone; oral

4.9

108.4

243

469

N05CF02

ATC

zolpidem; oral

1.7

108.2

2554

15403

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

108.1

1205

5773

177

Kela drug reimbursment

Insulin glargine 300 U / ml

4.0

108.0

320

770

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

3.1

108.0

481

1509

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.4

107.8

807

3294

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

5.0

107.8

237

450

SPAT1211

SPAT

Application of soft bandage

1.9

107.7

1503

7780

ZY000

NOMESCO Finland

Hospital inpatient

4.9

107.5

242

469

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

4.1

107.1

303

705

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

3.6

106.5

360

950

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.1

106.2

1158

5502

E61.2

ICD-10 Finland

Magnesium deficiency

26.6

106.1

E11.1

ICD-10 Finland

Type 2 diabetes mellitus, with ketoacidosis

6.6

105.7

174

250

S72.0

ICD-10 Finland

Fracture of neck of femur

2.2

105.6

899

3878

H05BX01

ATC

cinacalcet; oral

6.7

105.4

171

242

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

3.9

105.2

325

806

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

8.2

105.2

143

165

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.5

105.0

699

2705

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

2.0

104.8

1218

5922

P72

ICPC

Schizophrenia

3.7

104.6

341

878

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

10.1

104.5

122

115

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

2.6

104.1

639

2378

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.1

104.0

1067

4955

Y94.0

ICD-10 Finland

Accident at home

3.3

103.6

407

1184

WVA20

NOMESCO Finland

Medicine administration

2.8

103.3

531

1804

H25.1

ICD-10 Finland

Senile nuclear cataract

1.5

103.3

5226

37272

N05AB03

ATC

perphenazine; systemic, rectal

2.7

103.1

595

2147

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.4

103.0

758

3070

P03

ICPC

Feeling depressed

2.0

103.0

1184

5733

183

Kela drug reimbursment

Lamotrigin and topiramate

5.6

103.0

199

336

K59.0

ICD-10 Finland

Constipation

2.1

102.8

1061

4937

K85.2

ICD-10 Finland

Alcohol-induced acute pancreatitis

7.3

102.6

154

200

J96.0

ICD-10 Finland

Acute respiratory failure

3.9

102.5

309

753

NHQ40

NOMESCO Finland

Amputation of toe

3.5

102.5

368

1011

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

4.2

102.2

277

624

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

11.3

102.1

110

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

3.2

101.5

421

1266

EBA00

NOMESCO Finland

Extraction of tooth

1.5

101.5

5298

37981

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

4.9

101.3

230

449

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.9

101.2

504

1683

G41.9

ICD-10 Finland

Status epilepticus, unspecified

6.4

100.7

171

254

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

100.6

2102

12255

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

3.1

100.4

439

1362

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.4

100.4

755

3087

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

3.5

100.3

364

1007

C08CA05

ATC

nifedipine; systemic

2.0

99.8

1113

5329

P01AB01

ATC

metronidazole; oral, rectal

1.4

99.6

5782

42247

U04

ICPC

Incontinence urine

2.0

99.2

1141

5523

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.4

99.1

364

1015

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

11.4

98.8

106

M79.6

ICD-10 Finland

Pain in limb

1.4

98.8

6546

48966

ZYC01

NOMESCO Finland

Remote contact by phone

2.1

98.7

961

4373

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

6.9

98.6

155

212

V03AE03

ATC

lanthanum carbonate; oral

9.5

98.5

120

H36.01

ICD-10 Finland

Diabetic maculopathy

4.4

98.2

253

548

H36.00

ICD-10 Finland

Diabetic background retinopathy

4.3

98.0

260

576

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.8

98.0

1561

8415

A02BA02

ATC

ranitidine; systemic

1.6

97.8

3137

20314

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

4.0

97.7

284

674

N05AD01

ATC

haloperidol; systemic

2.5

97.5

651

2521

R00.1

ICD-10 Finland

Bradycardia, unspecified

2.4

97.5

679

2682

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

4.7

97.3

228

457

K86.1

ICD-10 Finland

Other chronic pancreatitis

4.8

97.3

225

446

H02AB04

ATC

methylprednisolone; systemic

1.7

97.3

2294

13797

N06AX26

ATC

vortioxetine; oral

2.1

97.1

1013

4731

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.9

96.8

1336

6882

XW000

NOMESCO Finland

Bone marrow biopsy

2.3

96.6

748

3097

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

2.1

95.7

993

4627

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.9

95.3

1388

7273

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.3

95.3

738

3056

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.0

94.9

1049

5004

SPAT1097

SPAT

Recording of ECG

1.6

94.8

2431

14924

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

2.5

94.7

600

2267

N05AN01

ATC

lithium; oral

3.2

94.6

384

1140

E89.00

ICD-10 Finland

Postirradiation hypothyroidism

12.4

94.5

K56.7

ICD-10 Finland

Ileus, unspecified

3.2

94.4

380

1122

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

2.7

94.3

542

1951

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

6.3

94.1

161

241

102

Kela drug reimbursment

Diabetes insipidus

14.4

94.0

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.7

94.0

1936

11230

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

3.5

94.0

337

925

J01DA01

ATC

[U] cefalexin

1.4

94.0

9339

74665

E27.2

ICD-10 Finland

Addisonian crisis

33.1

93.9

WX402

NOMESCO Finland

General anaesthesia

1.5

93.6

3129

20424

I20.00

ICD-10 Finland

Unstable angina

2.7

93.3

509

1784

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.2

93.0

860

3832

R40.2

ICD-10 Finland

Coma, unspecified

4.7

92.9

220

445

E87.3

ICD-10 Finland

Alkalosis

879.4

92.8

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.0

92.7

1155

5746

U05

ICPC

Urination problems other

2.1

92.5

991

4673

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

2.6

92.3

542

1972

E78.29

ICD-10 Finland

Other mixed hyperlipidaemia

8.7

92.2

120

131

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.9

92.2

440

1435

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.3

92.2

721

2998

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.6

92.1

564

2096

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.0

92.1

1015

4836

N05AF05

ATC

zuclopenthixol; systemic

4.7

91.7

216

435

E000001, ,

ATC

1.6

91.6

2881

18542

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.6

91.6

569

2129

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.1

91.5

974

4581

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

2.3

91.5

760

3242

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.6

91.2

558

2072

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

91.2

6179

46208

D64.8

ICD-10 Finland

Other specified anaemias

3.1

91.2

393

1209

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

3.5

90.8

317

855

J01CF05

ATC

flucloxacillin; systemic

2.0

90.7

1080

5288

R31

ICD-10 Finland

Unspecified haematuria

1.7

90.6

1778

10171

F60.9

ICD-10 Finland

Personality disorder, unspecified

4.9

90.6

205

399

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.1

90.5

398

1239

P20

ICPC

Memory disturbance

1.6

90.4

2649

16770

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

90.3

6532

49372

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

6.6

90.2

148

212

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

2.1

89.9

902

4148

K70.9

ICD-10 Finland

Alcoholic liver disease, unspecified

8.3

89.9

121

138

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.4

89.8

621

2444

N17

ICPC

Vertigo/dizziness

1.7

89.7

2086

12482

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.8

89.7

1631

9132

G40

ICD-10 Finland

Epilepsy

4.9

89.6

202

392

P01

ICPC

Feeling anxious/nervous/tense

1.9

89.4

1284

6693

R07.3

ICD-10 Finland

Other chest pain

1.8

89.1

1593

8874

SPAT1172

SPAT

Guidance concerning hydration

2.7

88.9

515

1861

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

2.3

88.7

683

2820

321

Kela drug reimbursment

Paricalcitol and cinacalcet

6.3

88.7

153

231

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.3

88.5

352

1032

XF402

NOMESCO Finland

ECG with work load test

1.8

88.3

1524

8403

B82

ICPC

Anaemia other/unspecified

2.6

88.2

549

2056

R04.0

ICD-10 Finland

Epistaxis

1.8

88.1

1318

6959

I35.0

ICD-10 Finland

Aortic (valve) stenosis

2.0

88.0

1091

5415

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.6

88.0

535

1981

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.4

87.8

653

2656

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.0

87.7

1094

5442

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.4

87.3

604

2377

D10

ICPC

Vomiting

2.3

87.3

685

2851

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

3.2

87.2

353

1046

D11

ICPC

Diarrhoea

1.8

87.2

1578

8820

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

3.1

87.1

372

1138

L17

ICPC

Foot/toe symptom/complaint

1.4

87.1

4623

33036

ZXA05

NOMESCO Finland

Left side

1.5

86.8

3808

26242

P76

ICPC

Depressive disorder

2.2

86.7

813

3642

F50.0

ICD-10 Finland

Anorexia nervosa

9.7

86.6

104

102

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.0

86.3

1053

5197

F61.0

ICD-10 Finland

Mixed personality disorders

4.0

85.8

254

611

B81

ICPC

Anaemia vit B12/folate deficiency

2.3

85.7

719

3078

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

4.2

85.7

232

522

E10

ICD-10 Finland

Type 1 diabetes mellitus

3.8

85.5

265

659

R52.9

ICD-10 Finland

Pain, unspecified

1.7

85.3

1567

8793

ZXA00

NOMESCO Finland

Right side

1.5

85.2

4059

28403

C01AA05

ATC

digoxin; systemic

1.7

84.8

1570

8827

A04AA01

ATC

ondansetron; systemic, rectal

1.8

84.8

1372

7416

A07AA02

ATC

nystatin; oral

2.0

84.7

1030

5077

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.4

84.7

615

2474

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

4.7

84.5

198

397

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

4.1

84.5

238

552

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.2

84.2

749

3284

JAH00

NOMESCO Finland

Laparotomy

2.5

84.1

531

2002

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

3.1

84.1

372

1162

U07

ICPC

Urine symptom/complaint other

1.8

84.1

1416

7746

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.4

84.0

609

2448

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.8

83.7

441

1518

C09CA06

ATC

candesartan; oral

1.5

83.6

3627

24914

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.7

83.3

1568

8855

Angiography of the heart and coronary arteries

2.0

83.1

972

4726

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

2.6

83.0

484

1755

E66.8

ICD-10 Finland

Other obesity

2.3

82.8

653

2723

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.0

82.7

897

4244

R4180

NOMESCO Finland

Podiatric therapy

3.9

82.7

247

598

SPAT1104

SPAT

Monitoring of emergency patient

1.9

82.7

1089

5515

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

4.8

82.3

191

380

H3601, E103,

ICD-10 Finland

5.9

82.2

152

246

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.3

82.0

638

2645

AN4

Balloon angioplasty and drug eluding stent

2.7

82.0

462

1646

K29.2

ICD-10 Finland

Alcoholic gastritis

10.0

81.9

SPAT1304

SPAT

Counselling and guidance related to ageing

1.8

81.7

1422

7852

S70.0

ICD-10 Finland

Contusion of hip

2.2

81.6

725

3177

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

10.2

81.6

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.7

81.5

1764

10346

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.2

81.4

339

1022

C10AA04

ATC

fluvastatin; oral

1.8

81.3

1297

6979

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

2.1

81.1

770

3465

F51.0

ICD-10 Finland

Nonorganic insomnia

1.6

80.8

2104

12924

C09DA01

ATC

losartan and diuretics; oral

1.7

80.8

1746

10233

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.5

80.7

516

1957

E66.01

ICD-10 Finland

Obesity due to excess calories

1.9

80.6

1067

5411

M05BA04

ATC

alendronic acid; oral

1.7

80.6

1653

9555

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.6

80.2

2308

14516

M48.0

ICD-10 Finland

Spinal stenosis

1.6

80.2

2106

12963

K65.0

ICD-10 Finland

Acute peritonitis

3.7

80.1

258

659

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

80.1

3087

20685

R06AE07

ATC

cetirizine; oral

1.4

80.0

6166

46815

E23.03

ICD-10 Finland

Lack of ACTH

11.1

79.9

F10.3

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Withdrawal state

8.1

79.6

109

127

F34.1

ICD-10 Finland

Dysthymia

2.5

79.6

501

1886

N05AA01

ATC

chlorpromazine; systemic, rectal

3.9

79.6

243

598

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.2

79.4

670

2875

OAB50, ,

SPAT

1.8

79.3

1291

6987

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.3

79.3

602

2470

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.4

78.8

574

2312

IAB10

NOMESCO Finland

Psychiatric consultation concerning substance abuse

13.6

78.7

I12.0

ICD-10 Finland

Hypertensive renal disease with renal failure

4.1

78.4

218

501

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

5.3

78.3

161

288

K85

ICPC

Elevated blood pressure

1.5

78.2

2787

18360

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.8

78.1

1269

6863

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

3.4

77.9

289

811

F50.9

ICD-10 Finland

Eating disorder, unspecified

6.4

77.8

131

193

L04AX01

ATC

azathioprine; systemic

2.2

77.8

657

2820

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

2.6

77.8

465

1707

C03BA11

ATC

indapamide; oral

2.5

77.6

529

2068

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

3.1

77.5

328

998

SPAT1251

SPAT

Organisation of medication

2.3

77.5

622

2613

N05BA09

ATC

clobazam; oral

6.4

77.4

131

194

NB6AA

NOMESCO Finland

Humerus X-ray examination

2.7

77.4

440

1575

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

4.9

77.2

173

334

U14

ICPC

Kidney symptom/complaint

3.2

77.2

312

924

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.6

77.0

472

1754

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.0

76.8

868

4167

D09

ICPC

Nausea

2.3

76.3

615

2588

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.1

76.2

794

3701

A99

ICPC

Disease/condition unspecnature/site

1.7

76.0

1637

9577

K90

ICPC

Stroke/cerebrovascular accident

2.5

76.0

493

1883

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.5

75.9

518

2025

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

3.4

75.7

286

812

D07AC01

ATC

betamethasone; topical

1.4

75.5

5468

40998

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.6

75.4

1754

10467

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

75.4

2997

20177

A10BK03

ATC

empagliflozin; oral

1.7

75.1

1497

8577

S22.3

ICD-10 Finland

Fracture of rib

1.8

75.0

1160

6178

U08

ICPC

Urinary retention

2.7

74.8

418

1483

WX725

NOMESCO Finland

Noninvasive ventilation

2.0

74.7

862

4168

SPAT1139

SPAT

Nutrition survey

2.3

74.4

580

2406

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

74.1

2660

17532

N05AB01

ATC

dixyrazine; systemic

3.6

74.0

250

660

D07AA02

ATC

hydrocortisone; topical

1.6

73.9

1900

11618

A07AA11

ATC

rifaximin; oral

8.4

73.7

110

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.7

73.7

1342

7498

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.7

73.7

1521

8796

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

4.1

73.6

209

488

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.6

73.6

447

1654

SPAT1053

SPAT

Memory test

1.5

73.4

2611

17171

C08DB01

ATC

diltiazem; oral

1.9

73.2

936

4688

ZXA10

NOMESCO Finland

Bilateral

1.5

73.2

2851

19102

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

6.4

73.1

123

181

201

Kela drug reimbursment

Chronic cardiac insufficiency

1.9

73.0

1061

5540

A10AD05

ATC

insulin aspart; parenteral

2.9

73.0

347

1129

C10AC01

ATC

colestyramine; oral

2.5

73.0

467

1772

R10.0

ICD-10 Finland

Acute abdomen

2.4

72.7

513

2037

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

7.7

72.6

104

128

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

4.0

72.5

212

506

R52.2

ICD-10 Finland

Other chronic pain

2.3

72.2

575

2407

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.5

72.0

477

1839

L04AD01

ATC

ciclosporin; systemic

3.1

71.9

302

915

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.6

71.7

423

1542

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.6

71.7

1974

12261

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

2.5

71.5

475

1834

ZZA00

NOMESCO Finland

Split skin graft

2.4

71.5

513

2052

3AC01, ,

NOMESCO Finland

4.3

71.5

189

418

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

5.6

71.1

137

231

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.8

70.9

364

1236

SPAT1307

SPAT

Psychosocial counselling and guidance

2.2

70.8

638

2810

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.8

70.8

1134

6102

S00.0

ICD-10 Finland

Superficial injury of scalp

2.6

70.7

433

1608

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

3.9

70.7

211

511

C09DA06

ATC

candesartan and diuretics; oral

1.8

70.5

1197

6553

A10BK01

ATC

dapagliflozin; oral

1.8

70.4

1164

6322

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

70.3

2903

19659

NFB20

NOMESCO Finland

Primary partial prosthetic replacement of hip joint using cement, other or unspecified

2.3

70.3

531

2173

2761A

ICD-9 Finland

Disorders of fluid, electrolyte and acid-base balance, Hyposmolality and/or hyponatraemia

+∞

70.3

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

5.2

70.2

148

271

N06AX12

ATC

bupropion; oral

2.0

70.2

756

3565

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.4

70.1

3554

25009

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.2

69.9

649

2893

WX213

NOMESCO Finland

Lower leg blockade

4.2

69.7

190

430

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

3.5

69.7

250

687

E66.9

ICD-10 Finland

Obesity, unspecified

2.5

69.6

463

1789

E23.2

ICD-10 Finland

Diabetes insipidus

11.1

69.5

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

7.7

69.5

121

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.5

69.5

449

1711

101

Kela drug reimbursment

Anterior pituitary hypofunction

5.5

69.5

137

236

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.7

69.5

1339

7596

SPAT1247

SPAT

Outpatient detoxication and monitoring

6.6

69.3

113

161

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

4.1

68.9

193

446

SPAT1279

SPAT

Preparation of immediate hospitalisation

3.5

68.9

242

656

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

8.4

68.8

104

OAA67, ,

SPAT

0.5

68.8

552

10766

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.6

68.6

1735

10556

WW200

NOMESCO Finland

Immunization

2.6

68.4

411

1512

R60.1

ICD-10 Finland

Generalized oedema

4.7

68.4

162

328

F10.4

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Withdrawal state with delirium

9.3

68.4

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

3.7

68.4

223

575

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

2.2

68.3

612

2690

Z93.2

ICD-10 Finland

Ileostomy status

6.9

68.3

107

146

UJF30

NOMESCO Finland

Ileoscopy through colon

1.6

68.1

1551

9193

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

5.2

68.1

143

261

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

4.0

67.9

200

480

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.1

67.8

711

3319

X58

ICD-10 Finland

Exposure to other specified factors

1.6

67.8

2002

12628

H02AB07

ATC

prednisone; oral

1.5

67.6

2065

13122

P74

ICPC

Anxiety disorder/anxiety state

2.4

67.6

503

2045

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

3.7

67.4

219

563

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

3.4

67.4

243

670

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.1

67.1

632

2833

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

4.2

67.0

182

411

D12

ICPC

Constipation

2.1

67.0

644

2910

SPAT1312

SPAT

General health counselling

1.4

66.9

4524

33394

I48.2

ICD-10 Finland

Chronic atrial fibrillation

1.9

66.9

837

4161

N06AB05

ATC

paroxetine; oral

2.0

66.8

796

3891

C10AX09

ATC

ezetimibe; oral

1.5

66.7

2080

13277

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

2.2

66.5

615

2737

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

3.9

66.5

198

479

J01FA06

ATC

roxithromycin; oral

1.3

66.4

5720

43829

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

7.0

66.4

103

139

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.5

66.2

2517

16747

N05AC02

ATC

thioridazine; oral

2.9

66.1

325

1078

XA400

NOMESCO Finland

EEG

5.4

66.1

134

237

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.9

66.0

852

4278

Z2221

NOMESCO Finland

Medical doctor

1.4

66.0

3675

26249

K86.3

ICD-10 Finland

Pseudocyst of pancreas

5.8

65.9

123

201

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.3

65.9

5482

41772

E16.19

ICD-10 Finland

Other specified hypoglycaemia

6.7

65.8

106

149

F05.8

ICD-10 Finland

Other delirium

3.9

65.6

194

467

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.5

65.5

419

1589

XA800

NOMESCO Finland

Neuropsychological investigation

2.3

65.5

517

2156

G62.1

ICD-10 Finland

Alcoholic polyneuropathy

6.7

65.4

106

150

C03DB01

ATC

amiloride; oral

11.9

65.2

78891

ICD-8 Finland

Other general symptoms, Hypokaliaemia

+∞

65.2

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

2.2

65.0

601

2675

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

2.9

64.9

314

1032

F32

ICD-10 Finland

Depressive episode

2.1

64.8

640

2922

N06AX05

ATC

trazodone; oral

2.7

64.8

368

1317

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.0

64.7

724

3460

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.9

64.7

864

4387

E26.9

ICD-10 Finland

Hyperaldosteronism, unspecified

11.2

64.6

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.6

64.6

1512

9020

N88

ICPC

Epilepsy

5.0

64.6

140

263

L76

ICPC

Fracture: other

2.2

64.5

578

2540

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.8

64.5

338

1160

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

2.5

64.4

413

1569

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.8

64.3

1079

5881

F10.01

ICD-10 Finland

Alcohol-related acute intoxication with permanent or other somatic damage

5.0

64.3

142

271

JFB00

NOMESCO Finland

Partial resection of small intestine

2.9

64.3

316

1048

ZXD35

NOMESCO Finland

Usual procedure

2.3

64.1

512

2146

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.4

64.1

453

1800

C07AB03

ATC

atenolol; systemic

1.8

64.0

980

5198

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

2.1

63.9

623

2829

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

7.3

63.9

125

F20

ICD-10 Finland

Schizophrenia

5.3

63.7

132

238

IGY99

NOMESCO Finland

Other psychiatric treatment contact

3.3

63.7

248

718

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

3.2

63.7

260

775

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

3.9

63.7

188

452

U71

ICPC

Cystitis/urinary infection other

1.8

63.6

1041

5632

Z08

ICPC

Social welfare problem

3.4

63.6

229

631

EBA30

NOMESCO Finland

Extraction of root of tooth

1.9

63.5

915

4762

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

2.8

63.4

327

1113

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.1

63.4

617

2801

B80

ICPC

Iron deficiency anaemia

2.5

63.3

416

1598

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.7

63.0

1394

8194

PE1AT

NOMESCO Finland

Femoral artery PTA

3.4

63.0

231

644

F10.06

ICD-10 Finland

Alcohol-related acute intoxication with seizures

13.4

62.7

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.7

62.7

352

1252

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

2.5

62.6

416

1607

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

2.1

62.6

624

2859

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.6

62.5

1581

9607

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.3

62.4

504

2122

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

2.5

62.3

394

1486

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.6

62.3

382

1420

U01

ICPC

Dysuria/painful urination

1.7

62.2

1152

6456

SPAT1227

SPAT

Substance abuse rehabilitation

5.3

62.2

127

226

E89.01

ICD-10 Finland

Postsurgical hypothyroidism

4.6

62.0

151

313

E16.0

ICD-10 Finland

Drug-induced hypoglycaemia without coma

6.1

62.0

109

168

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.5

61.9

395

1497

ZYB02

NOMESCO Finland

Outreach service at unit of another specialty

7.8

61.8

105

M10.0

ICD-10 Finland

Idiopathic gout

2.2

61.7

560

2473

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.6

61.7

1487

8929

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

3.4

61.7

223

616

S76

ICPC

Skin infection other

1.9

61.6

841

4300

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

2.7

61.6

334

1167

R4120

NOMESCO Finland

Occupational therapy

1.9

61.4

865

4468

SPAT1281

SPAT

Other administrative function

1.7

61.4

1137

6372

R13

ICD-10 Finland

Dysphagia

1.7

61.4

1100

6108

188

Kela drug reimbursment

Psychosis requiring demanding treatment

4.1

61.4

172

398

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.9

61.3

803

4051

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.5

61.2

386

1454

ZXH04

NOMESCO Finland

Procedure performed in other inpatient unit

5.0

61.2

134

254

Z00.8

ICD-10 Finland

Other general examinations

1.7

61.2

1142

6415

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

3.3

60.9

240

700

J94.8

ICD-10 Finland

Other specified pleural conditions

2.7

60.7

329

1149

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

2.9

60.5

285

923

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.9

60.5

805

4082

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.0

60.4

689

3316

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.2

60.3

521

2256

J96.1

ICD-10 Finland

Chronic respiratory failure

2.4

60.2

422

1670

Z94.4

ICD-10 Finland

Liver transplant status

6.9

60.1

128

D50.8

ICD-10 Finland

Other iron deficiency anaemias

3.0

60.0

276

882

H3601, E113,

ICD-10 Finland

3.1

60.0

252

764

K29.7

ICD-10 Finland

Gastritis, unspecified

2.1

60.0

572

2576

JFF13

NOMESCO Finland

Terminal enterostomy

7.3

60.0

117

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

3.2

59.7

248

747

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.2

59.7

522

2272

N02BF01

ATC

gabapentin; oral

1.6

59.6

1486

8994

F10.02

ICD-10 Finland

Alcohol-related acute intoxication with other acute clinical complications

8.9

59.5

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

6.0

59.4

107

169

IGV01

NOMESCO Finland

Psychiatric network contact

4.5

59.3

147

309

R95

ICPC

Chron obstructive pulmonary disease

2.2

59.3

530

2326

K85

ICD-10 Finland

Acute pancreatitis

2.9

59.3

291

964

P18

ICPC

Medication abuse

5.1

59.2

126

233

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

2.4

59.1

436

1765

I25

ICD-10 Finland

Chronic ischaemic heart disease

2.0

59.1

696

3386

XX3DW

NOMESCO Finland

Time consuming IT work

1.6

59.0

1643

10207

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

3.3

58.9

227

653

U02

ICPC

Urinary frequency/urgency

1.5

58.9

2203

14581

KBV00

NOMESCO Finland

Insertion of stent into ureter

4.6

58.8

143

296

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

3.1

58.8

255

788

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

3.2

58.7

239

711

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

3.0

58.7

262

823

Z71.4

ICD-10 Finland

Alcohol abuse counselling and surveillance

5.8

58.6

110

181

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

3.6

58.5

201

537

XF602

NOMESCO Finland

Bloodpressure monitoring

3.5

58.1

202

544

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

4.8

58.1

133

262

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

2.7

58.1

329

1176

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.6

58.0

1491

9088

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

3.0

58.0

269

864

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

3.3

58.0

226

655

PG5AC

NOMESCO Finland

Contrast examination of injection gate to artery or vein

12.4

58.0

F50.1

ICD-10 Finland

Atypical anorexia nervosa

8.6

57.9

W06

ICD-10 Finland

Fall involving bed

3.6

57.8

191

497

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

3.0

57.7

264

841

C09CA07

ATC

telmisartan; oral

1.7

57.7

1121

6362

S72.1

ICD-10 Finland

Pertrochanteric fracture

2.3

57.7

461

1932

UJD02

NOMESCO Finland

Gastroscopy

1.9

57.6

755

3809

G40.89

ICD-10 Finland

Other epilepsy

6.0

57.5

104

165

N18

ICPC

Paralysis/weakness

2.6

57.5

342

1253

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

4.1

57.2

160

370

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

7.1

57.1

118

RS220, ,

NOMESCO Finland

3.4

56.9

210

588

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

2.4

56.7

389

1525

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

56.6

4190

31211

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

56.5

3609

26270

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

3.7

56.5

183

470

BC4WT

NOMESCO Finland

Selective blood sample from adrenal gland with radiological guidance

13.3

56.4

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.8

56.3

909

4894

K76.7

ICD-10 Finland

Hepatorenal syndrome

8.8

56.3

WX704

NOMESCO Finland

Intubation

1.7

56.3

1134

6500

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

2.6

56.2

341

1261

C07BB07

ATC

bisoprolol and thiazides; systemic

2.0

56.2

615

2915

Z71.9

ICD-10 Finland

Counselling, unspecified

1.7

56.1

1054

5926

RD210, ,

NOMESCO Finland

3.0

56.0

247

771

F03

ICD-10 Finland

Unspecified dementia

1.8

55.8

831

4365

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

2.5

55.8

376

1462

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

2.2

55.8

495

2167

K02.1

ICD-10 Finland

Caries of dentine

1.3

55.7

7895

64310

N03AX11

ATC

topiramate; oral

2.7

55.7

301

1050

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.0

55.7

255

813

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

3.6

55.7

189

501

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.4

55.4

393

1564

I15.9

ICD-10 Finland

Secondary hypertension, unspecified

3.9

55.3

164

396

C08CA10

ATC

nilvadipine; oral

2.5

55.2

348

1311

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.3

55.1

446

1880

Y96.9

ICD-10 Finland

Unspecified type of accident

2.6

55.0

319

1154

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

54.8

470

2029

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

54.8

2885

20322

130

Kela drug reimbursment

Malignant tumour

1.6

54.7

1486

9171

U13

ICPC

Bladder symptom/complaint other

2.2

54.6

462

1984

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3018405) Lactate [Moles/volume] in Arterial blood

1448

4629

3.13

320.01

6.4

3.7

1.52

1.38

mmol/l

2.39

1408

4568

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

11254

81399

1.91

319.73

5.9

3.2

81.23

50.12

u/l

83.60

10586

75159

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1199

3428

3.47

317.57

1.7

1.5

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2624

11424

2.38

316.19

7.3

3.4

1.21

1.23

mmol/l

26.33

2402

9572

(3017181) Myelocytes/Leukocytes in Blood

2745

12217

2.33

314.35

5.2

4.2

0.95

0.97

0.11

1186

3752

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

3855

13092

3.30

307.65

2.8

2.2

0.19

0.20

g/l

15.62

3517

12193

(40767503) Oxygen content in Capillary blood by calculation

1289

2746

4.70

307.65

3.9

2.4

15.39

16.46

24.24

1261

2687

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2576

9039

2.99

307.65

14.3

8.2

1.37

1.33

1.13

2556

8990

(3027801) Oxygen [Partial pressure] in Arterial blood

4691

15855

3.48

307.65

11.0

6.7

11.43

12.36

kpa

30.33

4515

15198

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1564

4737

3.32

307.65

2.9

3.3

48.30

41.99

mg/l

1.01

1272

3989

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

8517

44125

2.65

307.65

4.5

3.0

2614.47

1413.20

ng/l

49.33

7662

37866

(3012501) Base excess in Blood by calculation

1174

2784

4.19

307.65

6.0

3.7

3.08

2.56

mmol/l

5.25

856

1892

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

5353

29973

2.00

307.65

2.0

1.7

18219492.47

32414631.00

pmol/l

1.42

4402

24298

(3000850) Epithelial cells [#/volume] in Urine

6391

31599

2.46

307.65

4.3

2.6

5.87

5.29

e6/l

2.68

6037

28610

(3036481) Cortisol [Moles/volume] in Serum or Plasma

5546

10529

6.90

307.65

2.4

407.26

373.84

nmol/l

16.70

5176

9711

(3035350) Ketones [Presence] in Urine by Test strip

10505

71307

2.03

307.65

6.5

4.0

6.39

3.57

estimate

0.87

2938

15208

(3021960) Folate [Moles/volume] in Serum or Plasma

7726

40904

2.44

307.65

2.2

1.7

19.60

20.35

nmol/l

3.90

6837

33827

(3034860) Kappa light chains.free [Mass/volume] in Serum

1565

4742

3.32

307.65

2.9

3.3

102.11

56.74

mg/l

0.67

1280

3984

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2487

8564

3.03

307.65

10.6

6.4

24.22

24.62

mmol/l

3.63

2406

8187

(3020891) Body temperature

1974

6863

2.93

307.65

8.6

4.0

36.94

36.89

°c

8.82

1936

6807

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2792

7587

3.95

307.65

5.7

3.3

2.13

1.92

mmol/l

1.57

2109

5676

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2906

12236

2.49

307.65

2.5

1.7

1.83

1.48

56.68

2424

10530

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

9412

60167

2.07

307.65

3.4

2.3

76.09

79.57

nmol/l

24.41

8584

53105

(3023368) Bacteria identified in Blood by Culture

9272

39128

3.74

307.65

6.6

4.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

545

363

14.57

307.65

1.3

1.2

164.94

159.39

mmol/24h

0.44

545

363

(3019309) Folate [Moles/volume] in Red Blood Cells

5582

25731

2.56

307.65

2.1

1.7

1292.20

1158.60

nmol/l

16.51

4318

19168

(3006315) Basophils [#/volume] in Blood

10816

67023

2.45

307.65

8.6

6.1

0.04

e9/l

0.13

9568

57107

(3015377) Calcium [Moles/volume] in Serum or Plasma

8129

48748

2.10

307.65

4.6

3.5

2.33

2.36

mmol/l

53.00

7436

43795

(3021447) Carbon dioxide [Partial pressure] in Venous blood

4896

13183

4.52

307.65

7.1

3.3

5.76

5.83

kpa

4.11

4749

12874

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

8505

41438

2.88

307.65

3.2

2.1

309.33

211.70

u/l

4.06

8144

38790

(3007853) Bacteria identified in Skin by Aerobe culture

3585

15712

2.46

307.65

2.4

1.7

—

(3008295) Osmolality of Serum or Plasma

1882

962

20.61

307.65

1.5

1.4

267.91

284.68

mosm/kgh2o

77.84

1493

691

(3027315) Oxygen [Partial pressure] in Blood

1179

2803

4.18

307.65

6.0

3.7

8.47

8.52

kpa

0.36

1145

2738

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

9333

61852

1.94

307.65

4.0

2.8

—

estimate

—

(3002030) Lymphocytes/Leukocytes in Blood

10150

62411

2.34

307.65

9.1

6.4

23.29

27.10

206.93

9734

58587

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

5234

27635

2.14

307.65

2.1

1.7

1.56

1.36

mg/l

2.69

4300

21519

(3033658) Prothrombin time (PT) actual/Normal

5722

33019

1.96

307.65

7.4

4.0

84.60

87.22

11.16

5593

32292

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

9574

53257

2.61

307.65

6.8

3.6

73.97

68.06

ng/l

0.14

8164

39422

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

7391

40859

2.25

307.65

4.8

3.2

42.29

35.04

u/l

2.10

6981

38188

(3003181) Sodium [Moles/volume] in Urine

4222

1445

36.38

307.65

1.6

1.2

56.97

66.88

mmol/l

13.24

3346

1123

(3020630) Protein [Mass/volume] in Serum or Plasma

3250

12005

2.92

307.65

2.8

2.6

64.57

66.43

g/l

29.19

2986

10837

(3002173) Hemoglobin [Mass/volume] in Arterial blood

3857

12929

3.35

307.65

12.2

7.5

116.60

120.89

g/l

29.23

3789

12605

(3024928) Oxygen saturation in Venous blood

1271

3043

4.17

307.65

4.5

2.9

62.25

60.32

1.97

1208

2940

(3022096) Basophils/Leukocytes in Blood

10025

61108

2.35

307.65

9.1

6.5

0.62

0.67

21.57

9551

56653

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1169

3193

3.63

307.65

3.3

2.1

123.75

129.10

g/l

9.65

1010

2376

(3024354) Oxygen [Partial pressure] in Venous blood

4005

11121

4.14

307.65

6.0

2.8

4.56

4.44

kpa

2.43

3870

10849

(3044640) Blood type and Crossmatch panel - Blood

7363

43647

2.05

307.65

3.8

2.5

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2947

7459

4.30

307.65

6.9

3.5

24.06

24.32

mmol/l

2.81

2899

7371

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

2073

5675

3.78

307.65

2.3

1.9

2.36

2.25

ug/l

0.12

1846

4964

(3018095) Leukocytes [#/volume] in Urine

8731

50174

2.33

307.65

6.6

3.8

128.12

114.71

e6/l

0.50

7085

35822

(3000991) Gas panel - Venous blood

3920

11174

4.00

307.65

13.3

7.7

—

(3019977) pH of Arterial blood

4709

15837

3.50

307.65

11.0

6.7

7.42

1.18

2760

8816

(3007930) Methemoglobin/Hemoglobin.total in Blood

1587

5284

3.02

307.65

7.6

4.8

0.86

0.88

0.48

1521

4956

(3028271) Lactate [Moles/volume] in Capillary blood

990

2063

4.74

307.65

2.7

1.7

1.72

1.70

mmol/l

0.19

965

2002

(3027945) Reticulocytes/Erythrocytes in Blood

4611

16565

3.23

307.65

3.0

2.4

1.99

1.75

34.23

4130

14571

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

3323

14669

2.41

307.65

3.8

2.7

10.53

9.77

umol/l

0.84

2904

12859

(36304419) Bacteria [Presence] in Urine

6733

36591

2.22

307.65

5.1

3.2

322.99

90.44

estimate

0.36

188

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

11556

63346

3.29

307.65

14.2

5.7

1.19

1.21

mmol/l

170.16

10986

57763

(3024561) Albumin [Mass/volume] in Serum or Plasma

11481

62393

3.30

307.65

8.7

4.7

33.03

35.28

g/l

273.45

10897

57907

(3016038) Potassium [Moles/volume] in Urine

1588

505

32.58

307.65

1.4

1.2

31.85

37.09

mmol/l

5.04

1399

423

(3022948) Iron [Moles/volume] in Serum or Plasma

6173

22912

3.43

307.65

4.0

2.3

10.93

12.71

umol/l

70.78

5745

21055

(3014007) Fractional oxyhemoglobin in Arterial blood

2590

9075

2.99

307.65

14.4

8.3

93.37

93.89

3.10

2568

9051

(3009261) Glucose [Presence] in Urine by Test strip

10527

71884

2.01

307.65

6.6

4.0

0.52

0.31

estimate

0.22

2755

14426

(3012544) pH of Venous blood

4898

13336

4.47

307.65

7.0

3.3

7.38

1.62

3113

7457

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

5604

19664

3.52

307.65

4.1

2.3

20.52

22.17

13.63

5233

18014

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

9763

62281

2.13

307.65

2.8

2.1

91.80

95.82

pmol/l

13.09

5791

32492

(3018418) pH of Serum or Plasma

8172

41584

2.65

307.65

7.8

3.8

7.40

0.36

6483

29918

(3013826) Glucose [Moles/volume] in Serum or Plasma

12999

79200

3.39

307.65

11.0

4.5

7.10

6.70

mmol/l

67.17

12727

75068

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2496

7891

3.32

307.65

12.9

8.3

24.05

24.39

mmol/l

3.50

2428

7679

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1785

5797

3.12

307.65

7.4

4.6

1.62

1.61

0.13

1719

5461

(3023183) Ammonium ion [Moles/volume] in Plasma

1725

2588

6.88

307.65

3.3

2.4

33.99

34.23

umol/l

0.10

1574

2303

(3016502) Oxygen saturation in Arterial blood

4268

14078

3.48

307.65

11.2

7.0

95.02

95.51

4.29

4147

13578

(3002582) Erythrocytes [#/volume] in Urine

8295

44863

2.46

307.65

5.5

3.3

82.06

94.52

e6/l

0.30

7028

34439

(3004789) Transferrin [Mass/volume] in Serum or Plasma

5924

21297

3.50

307.65

4.0

2.3

2.20

2.30

g/l

31.25

5515

19409

(3013115) Eosinophils [#/volume] in Blood

10969

68910

2.43

307.65

9.1

6.3

0.19

e9/l

5.15

9797

59714

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

4692

15859

3.48

307.65

11.0

6.7

4.95

5.10

kpa

15.38

4524

15215

(3019198) Lymphocytes [#/volume] in Blood

10897

68259

2.43

307.65

8.8

6.2

1.72

1.90

e9/l

11.88

9782

59648

(3010421) pH of Blood

1563

4244

3.72

307.65

6.0

3.2

7.41

1.04

1530

4187

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

12319

71430

3.32

307.65

10.3

6.5

12.02

11.97

umol/l

0.12

11871

67813

(3042936) Bacteria identified in Isolate by Culture

4422

19252

2.58

307.65

2.8

2.0

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

11634

75313

2.47

307.65

14.0

9.5

4.73

4.16

e9/l

91.52

10426

65087

(3013290) Carbon dioxide [Partial pressure] in Blood

1175

2785

4.19

307.65

6.0

3.7

4.99

5.01

kpa

0.23

1141

2720

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2375

7140

3.48

307.65

5.5

2.6

0.65

0.62

3.15

2369

7113

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

3197

8938

3.92

307.65

6.1

3.4

5.12

5.17

kpa

2.13

3079

8470

(3021901) Oxygen saturation in Capillary blood

1372

2656

5.21

307.65

4.2

2.7

89.42

89.80

1.05

1337

2587

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1810

4036

4.61

307.65

1.5

1.2

—

(3001604) Monocytes [#/volume] in Blood

10774

66753

2.44

307.65

8.6

6.1

0.66

0.60

e9/l

36.90

9531

56847

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

1174

1375

8.57

307.65

1.5

1.3

525.39

280.94

pmol/l

1.75

908

1177

(3002032) Base excess in Venous blood by calculation

4779

12803

4.51

307.65

7.1

3.3

1.87

1.88

mmol/l

0.05

4205

11217

(3023520) Reticulocytes [#/volume] in Blood

3775

12999

3.24

307.65

3.0

2.5

72.16

67.76

e9/l

9.27

2894

9801

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

4327

16427

2.99

307.65

4.0

4.5

246.92

247.96

u/l

0.13

4080

15535

(3026782) Osmolality of Urine

7462

25794

4.10

307.65

4.0

2.8

428.85

540.84

mosm/kgh2o

307.65

6615

22499

(3014111) Lactate [Moles/volume] in Serum or Plasma

4008

11815

3.88

307.65

10.9

6.6

1.44

1.36

mmol/l

2.89

3913

11555

(3015736) pH of Urine

8636

56328

1.91

307.65

5.4

3.6

6.43

6.26

34.02

4807

31029

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1398

4203

3.32

307.65

2.3

1.6

0.42

0.31

mg/l

8.54

801

1951

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

12570

70624

3.67

307.65

15.4

6.2

1.19

1.21

mmol/l

164.19

10965

59872

(3032080) INR in Blood by Coagulation assay

11792

65063

3.36

307.65

21.1

16.1

1.28

1.30

inr

3.27

10351

54344

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

4319

15938

3.09

307.65

2.4

1.8

—

(3037467) Urinalysis macro (dipstick) panel - Urine

12857

91421

2.37

307.65

7.8

4.6

701.09

2.38

0.48

156

(3018677) aPTT in Platelet poor plasma by Coagulation assay

4743

19427

2.81

307.65

2.7

2.0

30.17

29.73

3.98

4614

18846

(3009343) pH of Capillary blood

3107

8705

3.89

307.65

6.1

3.4

7.41

7.42

5.06

2710

7171

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3424

9819

3.87

307.65

2.1

1.6

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2411

7199

3.51

307.65

5.5

2.6

1.32

1.22

5.03

2405

7166

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2526

8711

3.04

307.65

14.5

8.5

0.64

0.65

0.87

2507

8667

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2241

6290

3.72

307.65

1.8

1.7

1.60

1.55

g/l

1.39

1969

5324

(3027273) Bicarbonate [Moles/volume] in Venous blood

2203

5943

3.86

307.65

6.4

2.9

25.05

25.32

mmol/l

2.22

2131

5767

(3003396) Base excess in Arterial blood by calculation

4682

15687

3.51

307.65

10.8

6.7

1.05

1.03

mmol/l

0.12

3891

12889

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1458

4437

3.29

307.65

4.0

2.8

0.32

0.36

iu/ml

4.04

857

2459

(3006504) Eosinophils/Leukocytes in Blood

10061

61121

2.37

307.65

9.0

6.4

2.56

2.86

32.20

9569

56668

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1393

3559

3.93

307.65

5.3

3.2

1.94

1.54

mg/l

36.54

1278

3160

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2290

6785

3.52

307.65

7.2

3.4

47.80

47.46

0.25

2248

6699

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1822

4773

3.91

307.65

2.4

2.1

602.36

609.03

ug/l

0.02

1747

4502

(3020779) Urea [Moles/volume] in Serum or Plasma

4418

11414

4.58

307.65

11.6

5.9

11.77

9.97

mmol/l

34.31

4249

10811

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

6194

23467

3.35

307.65

2.5

1.9

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

8087

35928

3.15

307.65

3.2

2.3

3.08

2.95

mg/l

3.97

7135

30731

(3001122) Ferritin [Mass/volume] in Serum or Plasma

9728

58075

2.37

307.65

4.8

2.9

181.60

142.81

ug/l

16.47

9038

53178

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

8682

43153

2.85

307.65

4.4

2.5

60.33

64.74

u/l

0.68

8211

39603

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1407

4169

3.38

307.65

2.9

3.3

5.37

7.37

ratio

0.26

827

2432

(3020191) Ethanol [Moles/volume] in Serum or Plasma

579

814

6.90

307.65

2.0

1.3

1.26

1.28

promille

0.08

462

632

(3011985) Renin [Units/volume] in Plasma

1312

1446

9.18

307.65

1.9

1.4

71.49

58.52

mu/l

0.61

1160

1278

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2154

7394

3.00

307.65

14.1

9.0

15.35

15.99

20.81

2105

7091

(3018010) Neutrophils/Leukocytes in Blood

9956

61021

2.31

307.65

8.8

6.3

61.08

57.74

128.37

9619

57808

(3022313) Gas panel - Capillary blood

1903

6256

3.10

307.65

6.7

3.6

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1961

4460

4.55

307.65

4.3

2.8

24.56

25.02

mmol/l

3.77

1923

4378

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

3102

14349

2.27

307.65

6.0

3.4

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

2943

9749

3.23

307.65

5.9

3.2

118.84

86.44

ng/l

28.86

2503

8239

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2367

8269

2.97

307.65

2.2

1.7

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

14033

103352

2.67

307.65

14.8

8.0

89.46

80.57

u/l

56.51

13593

97249

(3019060) Gas panel - Arterial blood

2561

8488

3.17

307.65

6.7

4.4

—

(3019069) Monocytes/Leukocytes in Blood

10094

61282

2.38

307.65

9.1

6.5

9.14

9.01

3.56

9613

56831

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

4660

17173

3.15

307.65

2.4

1.8

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

6035

16677

4.75

307.65

9.8

4.8

1.07

1.03

mmol/l

15.91

5738

15303

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2955

8434

3.79

307.65

11.7

7.2

24.49

24.88

mmol/l

4.49

2918

8368

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

9044

49604

2.55

307.65

5.6

3.3

—

1.92

—

(3030467) Casts [#/volume] in Urine by Automated count

7262

38866

2.33

307.65

5.2

3.2

0.57

0.44

e6/l

3.85

6023

28857

(3028626) Oxygen [Partial pressure] in Capillary blood

1570

3205

4.98

307.65

5.4

3.1

8.04

8.13

kpa

1.13

1537

3130

(3028026) IgM [Mass/volume] in Serum or Plasma

1959

7302

2.73

307.65

2.0

2.1

1.31

1.43

g/l

1.15

1785

6653

(3005719) IgG [Mass/volume] in Serum or Plasma

2392

9462

2.61

307.65

3.1

3.0

10.63

10.66

g/l

0.12

2203

8707

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

4956

25579

2.17

307.65

6.2

3.7

245.94

473.48

ng/l

3.81

4290

20768

(3031040) Bacteria [#/volume] in Urine by Automated count

13029

89081

2.67

307.65

8.4

4.8

1705.50

1990.38

e6/l

0.26

254

1146

(1616796) Gas panel - Central venous blood

1445

2819

5.18

307.65

5.3

3.5

—

(3021601) Nitrite [Presence] in Urine by Test strip

10400

70390

2.02

307.65

6.5

4.0

0.00

estimate

3.97

2890

14701

(3012095) Magnesium [Moles/volume] in Serum or Plasma

7667

21431

5.35

307.65

5.0

3.1

0.78

0.82

mmol/l

100.12

7295

19969

(3004119) Hemoglobin [Mass/volume] in Venous blood

2882

8067

3.85

307.65

5.6

2.9

122.49

128.68

g/l

37.49

2798

7828

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

5672

33467

1.90

302.91

3.7

2.4

—

(3020682) Albumin/Creatinine [Ratio] in Urine

7177

45781

1.83

297.71

5.4

3.9

23.55

6.62

mg/mmol

11.24

4941

27229

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

4029

21272

2.03

297.13

4.7

3.1

2.99

2.62

e6/l

1.09

2308

10453

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

968

2520

3.78

294.49

7.5

4.6

946.99

1370.60

iu/ml

0.26

173

343

(3009508) Creatinine [Moles/volume] in Urine

7263

46684

1.82

292.14

4.5

3.2

5.95

7.39

mmol/l

169.58

6159

38444

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1182

3539

3.31

290.42

1.8

1.5

—

(3002179) Metamyelocytes/Leukocytes in Blood

2598

11681

2.29

288.54

5.0

4.1

0.71

0.70

0.09

1122

3601

(3021440) Promyelocytes/Leukocytes in Blood

2589

11681

2.28

284.91

5.2

4.2

0.13

0.11

0.73

1029

3244

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

2627

11944

2.27

283.74

3.3

2.3

6.35

7.05

ug/l

0.90

2217

10378

(3019230) Fractional oxyhemoglobin in Venous blood

991

2688

3.63

283.70

4.7

2.7

61.52

61.00

0.27

981

2679

(3022806) Fractional oxyhemoglobin in Capillary blood

725

1580

4.47

280.10

2.5

1.6

88.88

89.52

1.68

711

1556

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1444

5017

2.87

274.01

7.2

3.6

24.76

24.99

mmol/l

1.52

1334

4573

(3017143) Hepatitis C virus Ab [Presence] in Serum

2560

11679

2.25

273.46

2.1

1.5

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

2473

11129

2.28

272.92

3.7

2.3

0.47

0.50

e6/l

0.32

2391

10667

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

4311

23910

1.94

272.35

4.5

3.0

1.33

1.29

e6/l

0.11

2607

13115

(3029937) Albumin [Presence] in Urine by Test strip

6518

41432

1.78

264.52

6.7

4.2

0.00

estimate

0.36

2584

13497

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

2584

12014

2.21

262.72

4.1

2.4

44.86

52.49

u/l

0.28

2195

10129

(3009466) Valproate [Moles/volume] in Serum or Plasma

715

1627

4.28

261.17

6.1

4.6

365.47

350.25

umol/l

1.78

630

1380

(3025159) Blasts/Leukocytes in Blood

2536

11768

2.21

258.77

5.4

4.4

0.14

0.36

1.85

957

3083

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1227

4033

3.01

256.82

1.5

1.4

231.40

269.76

ug/g

7.93

772

2369

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1208

3936

3.04

256.75

2.2

1.6

—

(3012516) Albumin [Mass/volume] in Urine

6915

45028

1.76

255.73

4.5

3.3

101.43

38.86

mg/l

32.04

4902

27653

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1087

3346

3.20

254.47

1.6

—

(3026493) Urate [Moles/volume] in Serum or Plasma

5684

35028

1.80

253.58

3.9

2.6

366.84

345.03

umol/l

29.73

4967

30205

(3021589) Normoblasts [#/volume] in Blood

8415

58051

1.73

252.01

23.2

11.3

0.00

e9/l

0.76

7136

47526

(3047181) Lactate [Moles/volume] in Blood

1170

3822

3.02

247.33

7.8

5.5

1.43

1.31

mmol/l

2.19

1048

3362

(3026250) Tacrolimus [Mass/volume] in Blood

331

379

8.37

245.08

49.3

35.4

7.10

7.13

ug/l

0.06

305

329

(3000012) Reticulocyte production index

785

2048

3.74

237.34

2.0

2.2

0.88

0.90

0.32

593

1368

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

4860

29053

1.81

236.67

3.7

3.1

2.47

2.46

mmol/l

5.89

4353

26057

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

2390

11202

2.18

236.23

4.2

2.9

308.17

217.67

ng/l

10.06

2223

10260

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1473

5580

2.63

235.34

1.4

1.6

8.90

18.40

iu/ml

1.99

137

(3007164) IgA [Mass/volume] in Serum or Plasma

4112

23398

1.87

234.68

1.8

1.5

2.95

2.54

g/l

15.58

2669

13784

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2854

14378

2.05

233.01

2.1

1.5

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

3097

16122

1.99

230.43

2.2

1.7

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

746

1937

3.75

226.99

4.0

2.5

13359.21

6282.41

u/ml

0.25

118

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

7818

53907

1.68

225.18

6.7

4.0

1.23

0.65

estimate

0.62

2381

12047

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

12510

97884

1.79

224.66

6.3

4.4

19.00

12.88

mm/h

219.67

11747

90360

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

852

2454

3.39

221.57

1.8

1.6

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

966

3015

3.14

220.33

1.6

1.4

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

164

23.26

218.17

1.3

1.4

13.95

19.22

pmol/l

0.29

134

(3037756) Immunofixation for Serum or Plasma

946

2945

3.14

216.64

1.5

1.6

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

12539

98620

1.77

215.44

5.7

4.2

15.44

14.93

pmol/l

75.60

11597

88833

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1456

5724

2.53

214.80

2.5

2.3

7.62

7.35

g/l

6.70

1322

5129

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1453

5708

2.53

214.69

2.5

2.3

3.67

3.73

g/l

0.56

1319

5115

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1454

5716

2.53

214.51

2.5

2.3

4.15

4.22

g/l

1.63

1321

5129

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

703

1823

3.75

214.17

7.2

6.0

12.90

11.98

mg/l

5.07

645

1672

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

668

1675

3.87

213.51

1.3

0.28

0.25

nmol/l

0.11

115

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

656

1635

3.89

211.45

1.3

0.89

2.69

nmol/l

0.75

625

1571

(40760892) CBC W Ordered Manual Differential panel - Blood

4658

28263

1.76

211.08

7.0

4.7

—

(3040151) Glucose [Moles/volume] in Capillary blood

606

1436

4.08

209.37

7.4

9.6

7.43

7.34

mmol/l

0.19

543

1170

(3037522) Nuclear Ab [Titer] in Serum

3118

16858

1.91

204.90

1.4

1.3

476.88

531.52

titre

1.00

692

3811

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

851

2582

3.21

203.23

1.6

1.4

—

(3043409) Potassium [Moles/volume] in Arterial blood

1116

3962

2.77

201.61

7.4

4.0

3.89

3.88

mmol/l

0.11

1106

3934

(3007566) Smooth muscle Ab [Titer] in Serum

981

3253

2.95

201.03

1.3

1.2

130.45

146.15

titre

0.20

112

270

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

667

1742

3.71

200.99

1.7

1.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

846

2575

3.20

200.94

1.6

1.4

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

338

510

6.35

195.96

2.1

2.0

105.52

118.66

umol/l

0.31

181

269

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1357

5395

2.49

194.83

2.6

2.3

3.02

2.91

g/l

3.43

1222

4801

(3034770) Mitochondria Ab [Titer] in Serum

963

3236

2.91

192.52

1.2

1297.37

911.98

titre

0.62

106

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1053

3740

2.76

189.80

1.5

1.3

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1003

3480

2.82

188.96

3.1

2.5

3.60

3.56

g/l

0.32

958

3328

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1391

5709

2.41

186.03

2.5

1.9

—

(40768797) Stomach Pathology biopsy report

3258

18358

1.83

185.97

1.4

1.3

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1220

4730

2.54

184.41

1.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1303

5215

2.47

184.07

2.3

1.8

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

568

1412

3.88

183.55

1.3

—

nmol/l

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

575

1442

3.85

183.53

1.3

0.19

0.20

nmol/l

0.23

431

1171

(3025941) Bacteria identified in Stool by Culture

1504

6427

2.32

183.43

1.5

1.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

722

2116

3.31

182.19

1.6

1.4

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

733

2181

3.26

180.47

2.0

1.3

—

(3042733) HLA Ab [Presence] in Serum

241

273

8.42

179.90

5.3

4.6

—

(3041096) Erythrocytes [Presence] in Urine by Automated

5582

36789

1.64

179.78

6.1

3.4

0.67

0.35

estimate

0.67

2322

11665

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1242

4919

2.49

179.31

2.5

2.3

10.21

10.41

g/l

0.62

1090

4271

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

15021

127207

2.04

174.76

41.7

15.9

26.99

26.06

mg/l

3.30

14229

105112

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

2862

15793

1.85

173.44

4.1

4.4

26.85

25.96

ug/l

0.03

2438

13078

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1283

5237

2.41

173.27

2.7

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

4376

27306

1.69

172.89

1.4

1.3

1.69

1.77

u/ml

0.13

1174

7142

(40758558) Short blood count panel - Blood

5947

40129

1.61

172.21

10.5

6.3

—

(3020876) Protein [Mass/time] in 24 hour Urine

573

1501

3.69

171.69

2.6

2.3

1.33

1.02

g/24h

2.00

371

797

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

722

2196

3.19

171.34

2.0

1.3

23.82

20.76

u/ml

0.21

(40768446) Kidney Pathology biopsy report

259

340

7.27

170.83

2.2

1.6

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

625

1745

3.46

170.13

1.8

1.4

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1559

7004

2.21

168.05

3.3

3.2

4.15

4.44

pmol/l

22.06

1371

6196

(3045716) Anion gap in Serum or Plasma by calculation

526

1318

3.85

168.00

4.4

2.7

10.78

10.48

mmol/l

0.73

520

1304

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

504

1226

3.96

167.78

1.3

13.42

11.57

u/ml

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

649

1876

3.35

167.28

2.0

2.2

32.52

32.39

0.29

643

1865

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

661

1939

3.30

166.39

2.0

1.4

143.50

151.30

au/ml

0.72

164

571

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1216

4933

2.42

166.27

2.6

2.5

0.77

1.04

g/l

1.30

1020

4128

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

659

1933

3.30

165.90

1.6

1.2

277.20

279.32

u/ml

0.06

420

1188

(3020911) Cortisol [Moles/time] in 24 hour Urine

238

300

7.56

162.62

1.4

617.43

171.00

nmol/24h

1.41

238

300

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

687

2099

3.17

161.71

1.6

1.2

27.07

42.48

u/ml

—

(3008037) Lactate [Moles/volume] in Venous blood

895

3173

2.75

161.38

5.5

2.9

1.58

1.61

mmol/l

0.41

878

3095

(40761536) Microorganisms panel - Urine sediment

2127

10924

1.95

159.49

7.2

3.9

—

(3037121) Protein [Mass/volume] in Urine

1138

4576

2.44

158.44

4.1

3.0

1093.67

523.09

mg/l

1.40

640

1837

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

288

464

5.93

156.38

1.8

1.6

9.29

8.96

nmol/l

0.02

243

372

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

468

1148

3.92

153.94

1.5

—

(3013512) EKG study

7031

50308

1.54

152.24

5.7

3.6

0.75

0.76

0.03

146

(3036489) Thrombin time

1064

4234

2.46

151.38

2.6

2.0

21.58

21.26

0.65

979

3735

(3044242) Glucose [Moles/volume] in Arterial blood

346

688

4.81

149.05

2.2

1.8

8.41

8.00

mmol/l

0.85

346

688

(3017569) Oxygen content in Arterial blood

357

735

4.65

147.49

2.3

2.2

15.09

15.96

4.43

357

735

(3003434) Protein [Mass/volume] in Pleural fluid

676

2160

3.03

147.26

1.5

1.4

29.41

46.90

g/l

0.68

599

1970

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

932

3555

2.55

144.93

1.7

1.6

0.23

g/l

0.79

881

3385

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

951

3684

2.52

143.14

1.7

1.6

1.15

1.18

g/l

1.48

905

3525

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

438

1092

3.85

140.79

1.7

1.4

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1004

4038

2.43

139.30

2.5

2.3

0.04

0.03

g/l

0.25

894

3585

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

939

3690

2.48

136.97

1.4

1.5

14.77

14.88

iu/ml

0.01

(3004809) Band form neutrophils/Leukocytes in Blood

701

2383

2.85

136.51

3.5

3.6

1.60

1.56

0.09

638

2122

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

774

2781

2.70

135.63

1.5

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

774

2781

2.70

135.63

1.5

1.4

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

746

2630

2.75

135.62

1.4

1.3

4.12

3.72

mmol/l

8.49

701

2487

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

830

3091

2.61

135.42

1.6

1.5

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

148

127

11.06

135.10

5.8

5.3

3395.17

3243.75

iu/ml

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

894

3477

2.50

133.25

2.8

2.3

89.33

91.14

1.26

869

3349

(3011397) Hemoglobin [Presence] in Urine by Test strip

4863

32831

1.55

132.13

5.9

4.0

0.29

0.27

0.04

389

(3048929) Epstein Barr virus Ab [Presence] in Serum

793

2929

2.63

131.50

1.5

1.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1593

7892

1.99

131.08

1.6

1.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

784

2886

2.63

130.88

1.6

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

370

867

4.09

129.52

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

540

1634

3.18

128.95

1.7

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

540

1634

3.18

128.95

1.7

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

540

1634

3.18

128.95

1.7

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

540

1634

3.18

128.95

1.7

1.4

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

804

3020

2.58

128.80

1.5

1.3

610.91

556.28

mg/l

0.65

765

2870

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

956

3915

2.38

127.17

2.6

2.3

0.00

g/l

0.62

824

3388

(3039000) Anion gap in Blood by calculation

732

2645

2.68

126.75

10.0

6.5

11.94

11.15

mmol/l

5.28

683

2346

(3018572) Chloride [Moles/volume] in Blood

732

2646

2.68

126.65

10.0

6.5

101.74

105.25

mmol/l

29.45

683

2347

(3028707) Methadone [Presence] in Urine by Screen method

421

1100

3.67

126.45

3.2

2.6

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

13965

118222

1.66

125.86

7.2

5.2

2.00

1.98

mu/l

0.73

13063

107209

(3023487) Leukocytes [#/volume] in Peritoneal fluid

270

503

5.12

125.43

2.6

1.9

1051.59

1805.59

e6/l

0.32

199

350

(3014051) Protein [Presence] in Urine by Test strip

5095

35083

1.53

124.99

4.7

3.0

0.13

0.08

0.66

126

1057

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

360

850

4.05

124.73

1.4

—

(3000494) Fungus identified in Specimen by Culture

2706

16039

1.70

124.02

1.7

1.4

—

(3010375) cycloSPORINE [Mass/volume] in Blood

250

440

5.41

123.70

32.5

27.9

106.74

112.03

ug/l

0.58

198

370

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

689

2445

2.72

123.56

1.3

84.29

158.15

titre

0.74

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

390

990

3.77

122.15

2.3

2.4

27.61

27.22

iu/ml

0.02

133

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

686

2444

2.71

122.07

1.3

197.00

265.68

titre

0.41

212

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

817

3180

2.49

121.39

3.0

2.5

222.84

196.45

10.15

782

3017

(3017732) Neutrophils [#/volume] in Blood

2796

16860

1.67

119.68

4.4

3.1

5.26

4.61

e9/l

2.31

2337

14228

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

703

2570

2.64

118.86

1.5

1.4

34.44

28.80

e6/l

0.11

554

1976

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

709

2605

2.63

118.67

1.6

1.5

620.20

2217.34

e6/l

1.17

599

2111

(3026692) Albumin [Mass/volume] in Peritoneal fluid

219

355

5.87

118.19

1.7

1.3

12.42

13.70

g/l

1.07

169

267

(3044290) Cell count panel - Cerebral spinal fluid

669

2408

2.68

116.62

1.6

1.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

548

1780

2.96

115.76

1.1

—

(3012565) Volume of 24 hour Urine

276

564

4.67

115.07

2.0

2.1

1927.65

1897.19

0.15

238

484

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

627

2203

2.74

114.54

3.5

1.6

0.96

0.84

nmol/l

2.20

520

1858

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

876

3630

2.34

113.20

2.7

2.4

0.00

g/l

-0.00

822

3379

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

614

2152

2.75

112.68

1.4

1.5

10.25

14.38

u/ml

0.64

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

253

493

4.89

111.62

18.6

17.7

1480.55

1375.44

nmol/l

1.10

243

475

(3038515) Glucose [Moles/volume] in Venous blood

703

2666

2.55

110.20

5.7

3.1

7.78

7.55

mmol/l

1.09

688

2599

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

232

429

5.15

108.71

2.5

1.7

9247.01

13146.54

e6/l

0.30

132

241

(3045414) Leukocytes [Presence] in Urine

2338

13776

1.69

108.20

2.8

2.0

0.02

0.01

estimate

0.23

459

2480

(21494890) Protein electrophoresis panel - 24 hour Urine

445

1332

3.20

108.12

2.0

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

302

696

4.14

108.09

1.4

1.2

83.79

81.54

0.21

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

310

732

4.04

107.39

2.6

2.3

16.76

17.48

nmol/l

0.56

288

691

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

276

599

4.39

106.80

2.5

2.2

95.84

95.88

0.00

270

567

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

728

2849

2.47

106.74

2.6

2.2

182.60

91.10

ug/min

3.99

440

1555

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

239

462

4.93

106.45

13.8

13.2

790.94

3658.11

nmol/l

0.51

230

442

(3003129) Base excess in Capillary blood by calculation

492

1587

2.98

105.18

3.3

2.3

0.28

0.75

mmol/l

1.16

465

1550

(3027456) Digoxin [Moles/volume] in Serum or Plasma

813

3369

2.34

104.93

3.7

3.3

0.87

0.80

nmol/l

2.48

637

2698

(3023199) Leukocytes [#/volume] in Pleural fluid

557

1927

2.78

104.73

1.6

1.4

6382.53

2312.73

e6/l

1.18

418

1360

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

444

1355

3.14

104.44

1.3

1.2

63.72

61.76

u/l

0.20

406

1174

(3024932) HLA-DR beta [Type]

180

273

6.26

103.85

1.1

1.2

—

(3024471) HLA-A [Type]

183

284

6.12

103.22

1.0

—

(3036603) Volume of Urine

312

769

3.87

101.89

1.7

1.6

2072.81

1843.40

3.37

300

746

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

234

462

4.82

101.68

2.7

2.3

56.50

52.00

umol/l

0.99

201

391

(3019550) Sodium [Moles/volume] in Serum or Plasma

15130

132408

1.75

100.56

54.7

18.6

136.93

139.75

mmol/l

307.65

14958

129399

(3036782) Glucose [Moles/volume] in Pleural fluid

454

1438

3.03

100.19

1.4

1.3

6.77

6.12

mmol/l

4.49

423

1338

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

220

420

4.98

99.42

3.1

2.8

0.60

0.62

mmol/l

2.72

220

420

(3042631) Mycobacterium sp identified in Specimen

565

2034

2.67

98.33

2.6

2.8

—

(3044007) Cell count panel - Peritoneal fluid

219

423

4.93

97.65

2.5

1.7

—

(3052851) Hemolysis interference index of Serum or Plasma

844

3666

2.23

97.34

4.8

3.2

1.98

1.91

index

0.11

476

1820

(40768806) Pleura Pathology biopsy report

490

1648

2.85

97.10

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

394

1174

3.21

96.43

1.7

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

394

1174

3.21

96.43

1.7

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

394

1174

3.21

96.43

1.7

1.6

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

15130

132663

1.73

96.28

54.7

18.8

3.99

3.98

mmol/l

1.79

14956

129440

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

1929

11113

1.72

96.17

4.2

2.6

52.47

65.14

ml/min/173m2

30.94

988

4558

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

162

239

6.43

96.01

1.3

1.2

398.92

265.77

pmol/l

2.02

106

175

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

330

886

3.56

95.18

1.4

1.3

2.38

2.23

mmol/l

0.60

304

816

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

442

1420

2.98

95.14

1.7

1.6

—

(4198724) Urine methamphetamine measurement

173

279

5.89

93.90

2.6

2.4

—

(3048689) Calprotectin [Mass/mass] in Stool

2458

15164

1.62

93.88

2.5

2.3

199.84

142.72

ug/g

7.65

1976

11822

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

743

3114

2.30

93.26

1.6

1.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

312

821

3.63

92.73

1.8

1.4

—

(3004451) EKG impression Narrative

285

706

3.85

92.43

1.5

1.2

—

(40757494) Bilirubin.total [Moles/volume] in Blood

278

679

3.90

91.96

3.2

1.9

20.76

29.38

umol/l

0.51

(3019225) pH of Specimen

2394

14747

1.62

91.82

8.2

3.7

7.38

7.36

16.08

1981

10347

(3028308) Erythrocytes [#/volume] in Pleural fluid

498

1742

2.74

91.64

1.6

1.4

52824.08

50645.88

e6/l

0.07

308

985

(3019150) Specific gravity of Urine by Refractometry

4515

31885

1.46

91.53

6.6

4.4

1.32

1.16

kg/l

0.21

3276

20895

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

396

1227

3.09

90.76

3.3

2.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

325

893

3.47

90.50

1.7

1.4

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

513

1835

2.68

90.38

2.5

2.7

604.95

1199.26

u/ml

0.40

501

1819

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

445

1483

2.87

89.67

1.3

537.58

513.00

u/l

0.06

421

1416

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

498

1776

2.69

88.25

1.6

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

489

1729

2.71

88.12

1.6

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

491

1741

2.70

87.99

1.6

1.4

—

(37021550) Renin [Units/volume] in Plasma --upright

146

212

6.53

87.87

1.4

1.2

162.38

51.13

mu/l

1.24

103

156

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

301

804

3.57

87.50

1.8

1.4

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

517

1892

2.62

87.03

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

120

141

8.06

87.01

10.6

10.5

5.61

5.57

mmol/l

0.03

120

141

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1059

5224

1.97

86.97

1.9

39.44

39.84

u/l

0.22

912

4598

(3044889) 12 lead EKG panel

11119

92128

1.40

86.92

6.0

4.2

0.35

3046.19

1.13

244

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

474

10631

0.40

85.63

1.9

2.0

3.29

3.47

ratio

2.15

382

8334

(3045788) Cell count panel - Pleural fluid

448

1541

2.78

85.10

1.5

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

408

1337

2.92

84.76

1.7

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

196

389

4.79

84.68

3.0

2.8

29.01

27.99

umol/l

0.48

135

297

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

188

361

4.95

84.43

4.5

2.7

4.82

4.98

kpa

1.03

188

361

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

188

361

4.95

84.43

4.5

2.7

10.39

10.02

kpa

0.73

188

361

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

253

617

3.90

83.89

1.5

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

253

617

3.90

83.89

1.5

1.4

—

(4035726) Immunohistochemistry procedure

2061

12509

1.63

83.32

1.5

1.4

—

(3045424) Erythrocytes [Presence] in Urine

1297

6955

1.82

82.24

2.7

2.1

0.00

0.16

estimate

0.64

345

1944

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

463

1650

2.69

82.15

1.1

1.66

1.53

g/l

7.18

419

1501

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

22.05

82.05

1.1

217.48

188.13

pmol/l

0.13

(3044927) Protein electrophoresis panel - Urine

415

1403

2.83

81.43

1.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

225

528

4.05

78.66

3.9

3.6

903.88

968.15

mg/l

0.02

165

356

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

145

236

5.83

78.01

1.3

1.2

13.85

16.00

pmol/l

0.22

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

457

1664

2.63

77.70

1.6

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

457

1667

2.63

77.42

1.6

1.4

—

(3023419) Bacteria identified in Sputum by Culture

492

1861

2.53

77.37

2.6

2.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

455

1657

2.63

77.33

1.6

1.4

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1038

5293

1.90

77.03

3.2

3.6

3213.96

1492.82

u/ml

0.34

891

4550

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

343

1076

3.04

76.98

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

739

3344

2.13

76.66

1.4

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

740

3352

2.13

76.56

1.4

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

156

279

5.30

75.94

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

731

3322

2.12

74.98

1.4

1.2

—

(3017354) Segmented neutrophils/Leukocytes in Blood

445

1629

2.61

74.84

3.4

3.8

62.51

57.47

5.00

391

1399

(21494755) Public health laboratory ask at order entry panel

341

8339

0.37

74.75

1.3

1.4

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

240

612

3.73

74.73

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

15.44

74.39

3.5

3.0

—

(3023420) DNA double strand Ab [Units/volume] in Serum

1002

5132

1.89

73.27

1.8

1.7

8.33

7.45

iu/ml

0.27

234

1219

(3000093) Morphology [Interpretation] in Blood Narrative

378

1294

2.79

72.46

1.1

—

(3011288) Drugs identified in Urine by Screen method Nominal

467

1785

2.50

71.83

4.1

2.6

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

509

2027

2.41

71.64

1.5

1.6

0.73

0.85

g/l

1.39

373

1566

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

306

938

3.11

71.46

1.3

1.2

97.30

109.62

pmol/l

2.82

306

938

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

318

1000

3.03

71.08

1.2

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

565

2366

2.29

70.90

1.5

1.2

—

(3010838) Calcium [Moles/time] in 24 hour Urine

510

2049

2.39

70.38

1.9

1.7

3.97

4.99

mmol/24h

9.75

433

1797

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

343

1136

2.88

69.91

1.4

1.3

1.36

1.46

nmol/l

0.78

312

1018

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

281

831

3.22

69.68

1.0

1.1

294.18

289.75

mg/l

0.30

250

750

(3002331) Protein [Mass/volume] in Peritoneal fluid

160

317

4.79

69.33

1.5

1.3

134.30

50.35

g/l

0.34

123

241

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

221

561

3.74

69.29

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

502

2020

2.38

69.03

3.1

2.0

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

602

2624

2.20

68.58

2.3

1.7

384.81

284.31

mu/l

5.75

555

2402

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

206

505

3.88

67.87

1.3

1.2

61.20

68.11

0.42

(3008757) Leukocyte morphology finding [Identifier] in Blood

407

1497

2.60

67.80

3.4

3.8

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

319

7702

0.38

67.73

1.7

1.8

3.19

3.48

mmol/l

4.27

223

5367

(3013005) Retinol [Moles/volume] in Serum or Plasma

200

482

3.94

67.48

3.2

1.6

1.97

1.91

umol/l

0.27

188

439

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

345

1181

2.79

66.15

1.3

11.64

14.55

u/l

0.85

312

1092

(3035880) pH of Pleural fluid

266

787

3.22

65.93

1.3

7.42

7.40

0.73

206

542

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

107

152

6.66

65.79

2.5

3.1

69.74

37.13

mg/l

0.70

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

707

3336

2.04

65.50

3.0

3.5

687.09

740.70

u/ml

0.08

643

3008

(3017937) Magnesium [Moles/time] in 24 hour Urine

23.13

64.93

1.2

1.3

—

(3006567) Chloride [Moles/time] in 24 hour Urine

31.95

64.82

1.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

157

325

4.58

64.56

1.2

1.1

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

13.62

64.36

13.3

8.6

139.35

452.14

e6/l

0.64

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

204

520

3.73

63.61

3.1

1.6

26.26

28.47

umol/l

1.92

196

488

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

484

1991

2.33

63.29

2.1

1.9

25.42

25.14

ug/l

0.03

466

1947

(3008116) Ketones [Moles/volume] in Urine by Test strip

133

243

5.19

63.28

1.7

1.4

0.43

0.32

mmol/l

0.27

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

323

1094

2.81

63.19

1.5

1.4

13.76

13.15

u/l

0.75

312

1050

(40762365) Oxygen content in Arterial blood by calculation

118

195

5.73

62.55

2.7

2.8

14.58

14.89

ml/dl

0.50

101

184

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

128

7.10

62.55

5.1

6.9

56.92

36.03

ug/min

2.08

100

(3006922) Hepatitis E virus Ab [Presence] in Serum

273

852

3.05

61.87

1.1

—

(4024509) Urine culture

1144

6424

1.73

61.34

2.6

1.9

—

(3004775) Volume in Urine collected for unspecified duration

284

915

2.96

60.87

2.4

2.2

727.63

655.78

1.86

186

588

(3005532) Lymphocytes/Leukocytes in Pleural fluid

197

508

3.68

60.43

1.5

1.4

60.87

64.27

0.63

160

416

(3042111) Morphology [Interpretation] in Bone marrow Narrative

531

2318

2.19

60.24

1.5

1.6

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

643

3022

2.04

60.18

1.7

3.15

11.64

iu/l

0.78

222

1099

(3016879) Cocaine [Presence] in Urine

547

2433

2.15

59.20

3.1

2.0

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

250

768

3.10

58.23

1.6

1.5

8.98

6.52

u/l

1.24

196

607

(3014148) Varicella zoster virus Ab [Titer] in Serum

339

1240

2.61

57.14

1.1

—

(3016750) Collection duration of Urine

224

654

3.25

56.79

2.3

2.2

506.11

500.14

min

0.33

157

467

(3000764) Benzodiazepines [Presence] in Urine

569

2618

2.08

56.38

3.2

1.9

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

224

657

3.24

56.37

1.4

1.3

1.28

1.22

nmol/l

0.29

169

490

(3017704) Immunofixation for Urine

231

693

3.17

56.01

1.5

1.6

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

757

3863

1.88

55.74

1.7

1.5

9.16

5.10

iu/ml

0.21

151

749

(4062490) Immunoglobulin typing, IgG

336

1243

2.58

55.36

1.5

1.4

—

(40761511) CBC panel - Blood by Automated count

14623

129983

1.45

54.96

36.1

14.4

—

5.29

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

241

752

3.05

54.68

1.3

35.67

25.12

u/l

1.26

212

619

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

244

769

3.02

54.41

1.3

110.86

89.32

u/l

1.61

219

649

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

677

3358

1.94

54.32

1.8

1.9

12.60

11.70

mg/l

1.63

612

3109

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

163

397

3.89

54.27

3.0

2.4

152.01

143.42

nmol/l

0.28

134

347

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

312

1124

2.64

54.24

1.7

1.5

—

(3028300) Cannabinoids [Presence] in Urine

566

2639

2.05

54.12

3.3

1.9

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

144

321

4.25

54.00

2.5

1.06

1.08

ug/l

0.04

139

307

(3027008) Opiates [Presence] in Urine

564

2632

2.05

53.79

3.1

1.9

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

18.88

53.66

1.2

—

mmol/l

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

339

1279

2.53

53.63

1.5

1.4

2.61

3.01

g/l

4.01

229

914

(3024139) IgG subclass 3 [Mass/volume] in Serum

338

1278

2.52

53.23

1.5

1.4

0.41

0.45

g/l

0.80

228

915

(3027135) IgG subclass 1 [Mass/volume] in Serum

338

1280

2.52

53.06

1.5

1.4

7.00

6.86

g/l

0.18

231

917

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

401

1649

2.32

52.50

1.1

95.03

6872.50

iu/ml

0.53

343

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

510

2324

2.10

51.84

1.3

34.08

37.32

u/l

0.33

435

1990

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

313

1161

2.57

51.31

1.5

1.6

29.71

25.80

u/ml

0.49

235

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

233

745

2.97

50.69

2.3

1.8

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

168

439

3.63

50.61

1.5

1.4

3.15

2.54

0.42

146

363

(3003694) ABO and Rh group [Type] in Blood

4616

35336

1.32

50.52

1.5

1.4

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

203

600

3.21

50.49

1.6

1.5

—

(3027944) Amphetamines [Presence] in Urine

547

2591

2.02

50.08

3.0

1.9

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

11854

102424

1.30

50.00

47.8

19.6

14.37

13.74

320.40

11768

100833

(3015171) Extractable nuclear Ab [Units/volume] in Serum

867

4764

1.75

50.00

1.3

1.2

0.97

0.86

u/ml

0.09

408

(3014271) Vancomycin [Susceptibility]

233

751

2.95

49.98

3.5

3.0

—

(37019676) Renin [Units/volume] in Plasma --supine

19.86

49.83

1.1

1.3

56.07

25.71

mu/l

0.53

(3000919) Neutrophils/Leukocytes in Pleural fluid

156

393

3.76

49.57

1.4

1.3

22.28

21.80

0.07

143

349

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

223

708

2.99

49.13

2.5

2.3

—

(3011412) CD3 cells [#/volume] in Blood

304

1138

2.54

48.92

2.1

2.4

1454.89

1115.97

e6/l

0.54

275

1026

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

10.17

48.47

3.8

4.1

2.24

2.27

mg/l

0.03

(3000330) Specific gravity of Urine by Test strip

1155

6906

1.62

48.36

5.7

3.4

1.02

ratio

8.23

1046

6196

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

228

742

2.92

48.08

1.2

1.1

33.02

21.61

u/l

2.20

205

646

(3020564) Creatinine [Moles/volume] in Serum or Plasma

15152

136163

1.48

47.97

53.3

21.1

91.52

78.54

umol/l

110.64

14995

134153

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

269

963

2.66

47.40

1.1

1.2

86.86

177.95

titre

2.73

166

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

13718

121270

1.35

47.27

9.3

6.3

41.93

39.28

mmol/mol

139.75

12762

111396

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

268

962

2.65

46.98

1.1

1.2

75.00

154.25

titre

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

227

749

2.88

46.71

1.2

1.1

96.45

79.91

u/l

1.72

206

652

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

413

1812

2.17

46.29

1.2

1.1

—

(3022145) Colonoscopy Study observation

2240

15527

1.41

45.85

1.5

1.4

—

(3042517) Benzodiazepines panel - Urine

9.80

45.58

2.4

2.7

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

15.47

45.51

3.5

4.5

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

13883

123129

1.35

45.34

39.9

15.7

72.83

77.16

ml/min/173m2

79.43

13324

114162

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

142

358

3.76

45.11

1.3

1.4

17.59

15.71

pmol/l

0.77

111

295

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

221

733

2.86

45.06

1.1

—

0.62

—

(3051611) Lipemic interference index of Serum or Plasma

324

1299

2.37

44.98

5.1

3.1

13.16

13.50

index

0.20

206

650

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

191

585

3.10

44.81

3.6

2.8

1.37

1.41

0.09

191

585

(3024891) Influenza virus A+B Ag [Presence] in Specimen

586

2973

1.89

43.88

1.3

1.2

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

181

545

3.15

43.72

1.6

1.4

1778323.25

1405837.91

iu/ml

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

240

846

2.69

43.63

2.1

2.2

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

14943

134293

1.42

43.52

21.6

12.0

25.62

25.37

u/l

0.48

14661

129323

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

212

708

2.84

42.70

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

212

708

2.84

42.70

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

212

708

2.84

42.70

1.7

—

(3018133) Calcium [Moles/volume] in Urine

189

4.80

42.05

2.0

1.8

2.01

2.89

mmol/l

3.71

170

(1761482) Bacteria [#/volume] in Urine by Culture

631

3321

1.82

42.05

6.6

4.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

211

709

2.82

42.03

1.7

—

(3049717) Cytology report of Urine Cyto stain

960

5681

1.63

41.79

2.5

2.8

—

(3012898) Urea [Moles/volume] in Urine

109

6.24

41.76

1.3

120.27

179.71

mmol/l

2.67

(3024666) Lithium [Moles/volume] in Serum or Plasma

171

512

3.17

41.71

16.8

13.2

0.67

0.62

mmol/l

2.00

156

469

(3009214) Lutropin [Units/volume] in Serum or Plasma

529

2639

1.92

41.70

1.6

1.4

12.55

11.10

u/l

1.16

423

2125

(3004716) Salmonella sp identified in Stool by Organism specific culture

861

4960

1.67

41.66

1.4

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

974

5793

1.62

41.53

1.1

0.92

7.31

u/ml

0.65

(3005322) IgE [Units/volume] in Serum or Plasma

1190

7434

1.55

41.08

1.5

1.3

330.54

250.20

u/ml

1.01

1106

6844

(21494815) CD4 cells/Lymphocytes in Specimen

257

970

2.52

40.72

2.1

2.2

40.75

38.27

1.48

248

951

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

161

472

3.23

40.67

2.2

1.7

3595.59

23690.35

u/ml

0.75

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

200

666

2.85

40.53

1.3

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

200

666

2.85

40.53

1.3

1.5

—

(3047189) Immunofixation for 24 hour Urine

185

591

2.97

40.40

1.6

1.7

—

(1175426) CD3 cells/Lymphocytes in Blood

241

887

2.58

40.23

2.0

2.1

74.52

71.27

2.29

232

847

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

351

1528

2.19

40.16

3.0

3.5

9.72

14.41

nmol/l

0.42

338

1487

(3020717) Zinc [Moles/volume] in Serum or Plasma

198

661

2.84

39.94

2.4

1.4

16.01

24.24

umol/l

4.67

187

603

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

712

3943

1.73

39.86

1.5

1.4

—

(36660697) Celiac disease serology panel - Serum

1450

9521

1.47

39.38

1.2

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

146

5.24

39.25

1.6

1.66

0.82

nmol/l

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

243

915

2.52

38.71

2.7

3.8

182.16

190.14

nmol/l

0.08

234

897

(40768441) Liver Pathology biopsy report

244

925

2.51

38.33

1.6

1.3

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

180

584

2.92

38.27

1.2

1.1

3.80

4.81

iu/ml

0.39

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

15.01

38.21

3.7

4.4

22910.00

193400.00

u/ml

—

(3043410) Blood group antigens tested for on Red Blood Cells

126

329

3.63

38.11

1.8

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

208

734

2.69

37.79

3.9

—

(3006576) Bicarbonate [Moles/volume] in Blood

135

372

3.44

37.66

6.8

5.9

24.95

mmol/l

0.01

124

328

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

197

678

2.76

37.57

1.3

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

155

468

3.14

37.34

1.3

1.2

—

(3023410) Appearance of Cerebral spinal fluid

267

1069

2.37

37.26

1.8

1.6

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

134

5.29

36.71

1.6

2.0

1.23

1.57

mmol/l

0.47

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

6.71

36.70

2.2

2.0

17.19

22.29

0.36

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

159

4.87

36.61

2.2

2.1

18.04

17.21

umol/l

0.24

159

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

14.58

36.55

3.8

4.1

—

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

108

5.86

36.55

2.4

2.0

56.42

58.50

0.13

(3001186) Copper [Moles/volume] in Serum or Plasma

110

270

3.85

36.38

1.7

1.3

16.70

16.56

umol/l

0.07

231

(3045142) Bone marrow Pathology biopsy report

341

1543

2.10

35.39

1.4

1.3

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

107

263

3.85

35.33

1.5

1.3

1.16

1.18

mmol/l

2.30

107

263

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

146

4.98

35.29

3.6

3.3

37.58

42.33

umol/l

1.06

122

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

170

564

2.86

34.75

1.1

—

1.27

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

118

315

3.54

34.58

1.1

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

198

4.30

34.47

1.4

11.18

11.57

0.05

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

251

1015

2.35

34.28

1.1

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

44.02

33.66

7.8

10.3

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

316

1416

2.12

33.66

1.3

1.2

—

(3020961) Endomysium IgA Ab [Titer] in Serum

898

5506

1.57

33.56

1.1

257.22

162.75

titre

0.29

153

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

223

4.03

33.43

1.5

11485.00

7091.30

u/ml

—

(3010503) CD19 cells [#/volume] in Blood

203

753

2.56

33.43

2.1

2.4

543.13

309.75

e6/l

0.28

196

729

(3017315) Amylase [Enzymatic activity/volume] in Urine

195

710

2.60

33.36

1.5

1.2

279.11

366.70

u/l

0.51

177

665

(40761539) Cells [Type] in Urine sediment by Light microscopy

115

313

3.48

32.75

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

160

531

2.85

32.72

1.1

1559.58

1553.01

miu/ml

0.02

160

531

(3026389) Candida sp identified in Specimen by Organism specific culture

390

1909

1.95

32.58

1.4

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

117

324

3.42

32.45

1.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

123

353

3.30

32.26

1.3

1.2

28.50

18.54

0.53

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

203

773

2.49

31.68

1.9

2.5

687.07

501.99

e6/l

0.47

160

640

(3037692) Legionella sp identified in Specimen by Organism specific culture

147

476

2.92

31.45

1.3

1.2

—

(3028433) Virus identified in Specimen by Culture

130

393

3.13

31.33

1.3

1.2

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

209

813

2.44

31.16

2.0

2.6

194.13

243.74

e6/l

3.13

180

711

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

13830

124028

1.28

30.95

6.5

5.3

6.33

5.95

mmol/l

111.12

12585

111897

(3006442) Creatine [Moles/volume] in Serum or Plasma

206

800

2.44

30.83

2.2

1.5

92.79

84.97

umol/l

0.95

206

800

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

144

468

2.91

30.62

2.1

1.8

178.18

161.43

1.08

137

443

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

748

4493

1.59

30.52

1.6

27.99

22.82

u/ml

0.57

117

951

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

118

342

3.26

30.49

1.0

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

113

3057

0.34

30.45

1.2

1.1

0.60

0.62

ratio

0.18

456

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

9.18

29.81

6.9

3.1

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

240

1013

2.25

29.73

1.3

515.86

699.39

titre

0.35

(3033923) Metanephrine [Moles/time] in 24 hour Urine

239

3.72

29.65

1.1

0.75

0.65

umol/24h

1.11

102

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

582

3308

1.68

29.61

1.3

1.2

0.66

14.64

u/ml

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

225

926

2.30

29.58

1.1

—

(4281824) Cell count and differential, peritoneal fluid

310

1452

2.03

29.39

1.3

1.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

233

984

2.25

28.84

1.3

55.83

72.43

titre

0.39

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

370

1860

1.89

28.58

1.8

1.6

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

290

1343

2.05

28.38

1.7

1.5

20.15

30.15

6.31

174

794

(3007461) Platelets [#/volume] in Blood

15159

137926

1.35

28.30

59.1

24.4

256.42

246.53

e9/l

47.65

14929

134518

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

132

428

2.92

28.23

1.7

1.3

3.20

3.76

umol/l

0.98

119

369

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

6.17

28.18

1.1

1.3

836.76

1109.88

u/l

0.10

(3010813) Leukocytes [#/volume] in Blood

15162

137985

1.35

28.01

59.1

24.4

7.46

6.74

e9/l

121.19

14895

133989

(3035941) MCH [Entitic mass]

15159

137957

1.35

27.98

58.8

24.3

30.45

30.40

2.43

15014

135953

(3024731) MCV [Entitic mean volume] in Red Blood Cells

15159

137962

1.35

27.92

58.9

24.3

91.71

91.48

6.60

15019

135955

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

113

337

3.17

27.91

1.2

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

138

3274

0.39

27.89

1.2

1.54

1.52

g/l

0.27

138

3274

(3026361) Erythrocytes [#/volume] in Blood

15159

137971

1.35

27.83

59.0

24.4

4.13

4.45

e12/l

307.65

14890

133961

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

15158

137967

1.34

27.76

60.7

24.8

37.23

40.48

172.21

15010

135902

(3000963) Hemoglobin [Mass/volume] in Blood

15159

137985

1.34

27.69

59.8

24.6

124.21

134.44

g/l

307.65

15019

136022

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

280

1294

2.05

27.57

1.3

—

(3020393) Adenovirus Ag [Presence] in Stool

136

4.58

27.50

1.6

1.4

—

(3022229) Phosphate [Moles/volume] in Urine

7.40

27.17

1.4

2.2

17.56

14.21

mmol/l

0.38

(3022621) pH of Urine by Test strip

1532

10822

1.37

27.11

4.1

2.7

6.14

6.06

2.91

1112

7370

(3023383) Lactate [Moles/volume] in Pleural fluid

135

454

2.81

27.03

1.3

3.58

3.40

mmol/l

0.19

120

420

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

7.26

26.72

2.8

2.7

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

199

814

2.32

26.59

2.0

2.5

0.90

0.63

e9/l

0.52

183

775

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

147

526

2.65

26.15

1.7

1.9

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

147

526

2.65

26.15

1.7

1.9

—

(40757373) Influenza virus identified in Isolate

225

3.61

26.08

1.6

1.4

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

221

3.63

26.01

1.3

1.4

537.35

698.22

mu/l

0.27

213

(3003327) Ova and parasites identified in Stool by Light microscopy

670

4073

1.57

25.97

1.7

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

38.87

25.95

4.8

5.6

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

148

534

2.62

25.90

1.8

1.9

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

315

1555

1.92

25.75

1.3

1.2

4.40

3.97

u/ml

0.22

157

711

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

101

298

3.20

25.43

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

261

3.37

25.37

2.2

1.9

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

225

3.57

25.34

1.3

1.4

74.74

72.07

1.07

217

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

226

3.55

25.18

1.2

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

6.74

25.03

1.8

1.6

163.00

183.64

ug/g

0.20

(3032057) Clostridioides difficile [Presence] in Stool

273

3.29

24.97

2.0

1.7

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1093

7401

1.42

24.85

1.2

102.56

131.81

u/ml

2.09

374

2683

(40768804) Tissue Pathology biopsy report

6404

53916

1.19

24.76

2.4

2.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

192

800

2.27

24.61

1.4

1.2

—

(21494434) Karyotype in Bone marrow

263

1240

2.01

24.57

1.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

611

3687

1.58

24.46

1.7

1.6

16306.67

14444.68

e6/l

0.49

437

2648

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

189

788

2.27

24.20

1.4

1.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

155

4.08

24.15

1.7

1.5

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

173

695

2.36

24.14

2.6

2.4

1137.01

1465.21

u/ml

1.02

168

684

(3026726) Creatinine [Moles/volume] in Specimen

5.01

24.09

2.8

1.9

266.31

383.29

umol/l

0.28

(3026051) Granulocytes/Leukocytes in Pleural fluid

107

339

2.98

23.91

1.4

21.76

24.48

0.41

286

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

267

3.26

23.82

2.2

1.9

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

129

456

2.68

23.56

1.2

1.3

121.83

354.80

ug/l

1.14

251

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

311

1576

1.87

23.52

1.3

1.2

4.73

4.48

u/ml

0.07

120

575

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

102

318

3.03

23.45

2.5

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

275

3.20

23.37

2.2

2.4

1428.35

324.53

ug/l

0.47

275

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

170

689

2.34

23.27

1.4

1.5

6.02

5.94

u/l

0.05

135

581

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

196

848

2.19

22.98

2.3

1.8

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

5.22

22.80

1.6

1.4

16.22

17.13

pmol/l

0.09

(3006571) Granulocytes/Leukocytes in Synovial fluid

339

1783

1.81

22.77

1.7

1.6

68.17

58.51

4.62

206

1103

(3034274) Bile acid [Moles/volume] in Serum --fasting

200

876

2.16

22.74

2.2

1.9

14.61

9.95

umol/l

1.20

157

634

(3000034) Microalbumin [Mass/volume] in Urine

222

1014

2.08

22.65

3.4

2.6

101.78

26.34

mg/l

3.52

164

690

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

242

1145

2.00

22.43

2.1

2.27

1.93

u/field

0.51

145

601

(3019832) Treponema pallidum Ab [Presence] in Serum

965

6516

1.42

22.26

1.9

1.6

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

185

795

2.20

22.07

1.3

1.4

15.80

13.29

umol/l

2.60

172

741

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

279

1403

1.89

21.65

3.6

3.7

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

145

3.97

21.25

1.1

—

(3016244) Insulin [Units/volume] in Serum or Plasma

135

514

2.48

21.25

2.6

3.2

22.61

25.65

mu/l

0.39

125

483

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

616

3845

1.53

21.24

1.3

54.91

39.49

u/ml

0.49

215

(4027681) Cerebrospinal fluid IgG ratio and IgG index

146

582

2.37

20.80

1.3

1.2

0.59

0.69

ratio

0.38

342

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

512

3095

1.57

20.39

1.3

1.2

2.98

3.68

u/ml

0.22

218

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

121

448

2.55

20.21

1.3

1.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

165

703

2.22

20.15

2.3

1.9

2.48

2.98

u/field

0.22

128

463

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

166

711

2.21

20.02

1.6

1.3

—

(1761868) Lipid panel - Serum or Plasma

4150

44406

0.84

19.74

4.2

3.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

2508

28138

0.81

19.72

3.1

3.4

0.81

0.79

ug/l

0.30

1822

19083

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2877

22874

1.22

19.64

1.3

41.48

36.49

iu/ml

0.80

908

7062

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

279

1449

1.83

19.60

1.1

117.92

115.62

0.47

254

1302

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

205

962

2.02

19.51

2.2

1.7

411.48

355.18

mu/l

0.92

165

754

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

575

3603

1.52

19.49

1.3

4.92

4.98

u/ml

0.01

381

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

178

795

2.12

19.34

1.1

324.24

286.84

mg/l

0.64

152

699

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

367

2071

1.68

19.31

2.7

2.1

2776.28

4743.67

u/l

0.97

119

784

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

183

831

2.09

19.05

1.2

44.19

42.05

mg/l

0.27

148

699

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

331

2.77

19.05

1.1

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

153

3.70

18.99

1.1

18.09

19.64

u/l

0.32

101

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

572

3602

1.51

18.95

1.3

6.56

4.65

u/ml

0.39

566

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

104

4.35

18.90

1.1

1.89

1.61

umol/24h

0.77

104

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

531

3295

1.53

18.85

1.3

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

154

3.68

18.82

1.2

1.4

7.65

296102.41

nmol/l

1.08

128

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

341

2.72

18.56

1.4

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

257

1326

1.84

18.47

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

118

4.08

18.46

1.2

0.40

0.38

u/ml

0.02

(3042010) Triglyceride [Moles/volume] in Pleural fluid

226

3.13

18.36

1.2

1.68

1.21

mmol/l

0.26

148

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

342

1921

1.69

18.33

2.6

2.1

31.81

25.68

mg/l

1.17

121

714

(4268621) Lupus anticoagulant assay

220

1083

1.92

18.28

2.3

2.2

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

350

2.67

18.19

1.6

1.5

0.37

0.39

ug/l

0.17

240

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

103

372

2.62

18.14

1.3

113.98

137.30

nmol/l

0.96

270

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

319

2.75

18.11

1.1

84.03

86.81

0.31

154

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

314

2.77

18.08

1.1

84.22

87.35

0.29

156

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

108

4.19

18.03

1.2

1.3

—

(21491868) Cryoglobulin [Mass/volume] in Serum

115

440

2.47

17.99

1.5

1.2

0.62

0.17

g/l

0.44

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

270

2.90

17.82

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

166

747

2.10

17.73

1.1

—

(3017509) Phencyclidine [Presence] in Urine

5.13

17.68

1.3

1.4

—

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

152

3.60

17.67

1.3

1.4

75.91

70.01

0.74

125

(3014891) Appearance of Pleural fluid

184

3.33

17.62

1.8

1.5

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

144

3.67

17.54

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

127

3.86

17.51

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

129

527

2.31

17.47

1.1

431.64

816.69

ng/l

0.55

133

(3034891) Synovial lining cells/cells in Synovial fluid

159

710

2.12

17.34

1.6

1.5

1.91

3.39

1.29

140

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

4.60

17.31

1.6

1.4

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

156

697

2.12

17.00

2.8

37.79

37.99

0.04

413

(40768443) Skin Pathology biopsy report

924

6490

1.36

16.81

1.3

1.2

—

(3028717) Thiamine [Mass/volume] in Blood

153

3.52

16.78

1.1

1.2

66.47

62.76

ug/l

0.56

153

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

220

1117

1.87

16.69

1.9

1.8

5.58

3.79

mg/l

4.09

206

1058

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

280

1530

1.74

16.64

1.1

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

200

3439

0.54

16.60

1.7

1.2

0.88

0.89

g/l

0.26

200

3429

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

926

6521

1.36

16.57

4.7

3.9

88.10

75.63

u/ml

0.50

888

6290

(3001019) Free T4 and TSH panel - Serum or Plasma

276

4339

0.59

16.49

1.7

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

183

3.25

16.42

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

131

555

2.23

16.32

1.1

1.16

1.08

u/l

0.38

240

(4195642) Thrombophilia screening test

266

1445

1.74

16.15

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

256

2.84

15.94

1.4

1.3

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

159

3.38

15.85

1.2

1.1

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

5.01

15.84

1.4

1.3

58.84

41.70

mg/l

0.80

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

366

2.50

15.69

1.2

1.3

0.32

0.30

g/l

1.63

295

(3006245) CD3-CD19+ cells/cells in Blood

105

413

2.40

15.54

2.1

2.4

9.35

10.84

0.66

378

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

152

3.41

15.52

1.2

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

23.03

15.46

6.5

9.9

109.31

1260.33

e6/l

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

293

2.68

15.37

1.2

1.46

1.62

mmol/l

0.57

177

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

458

2882

1.51

15.30

1.1

21.50

9.80

eliau/ml

0.36

281

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

176

856

1.95

15.25

1.2

9.72

8.95

mmol/l

1.33

166

795

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

340

2.53

15.05

1.2

1.3

113.14

110.36

0.43

304

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

194

3.06

14.95

1.3

185.74

79.19

u/l

0.66

139

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

212

1103

1.82

14.93

1.1

1.2

100.44

95.24

2.05

197

1027

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

266

1479

1.70

14.90

1.2

34.06

42.88

u/ml

0.30

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.31

14.44

1.1

—

(44786800) Granulocytes/Leukocytes in Body fluid

179

3.11

14.37

1.4

1.3

22.38

24.22

0.16

142

(3046861) Legionella sp Ag [Presence] in Urine

4.17

14.22

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

171

3.15

14.15

1.2

1.5

—

(3024869) Neuronal Ab [Presence] in Serum

253

2.72

14.04

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

124

550

2.13

13.87

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

4.64

13.69

1.1

1.2

1.33

1.84

iu/ml

0.76

(3010370) Gastrin [Moles/volume] in Serum or Plasma

185

3.01

13.62

1.6

1.5

57.86

62.36

pmol/l

0.12

148

(3051339) Copper [Moles/volume] in Blood

4.88

13.59

2.0

1.1

15.26

16.76

umol/l

0.71

(3004616) Nuclear Ab [Presence] in Serum

301

1771

1.61

13.59

1.4

1.3

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

314

1868

1.59

13.54

1.2

2.76

5.01

u/ml

0.73

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

12999

118146

1.16

13.45

5.0

4.2

1.34

1.25

mmol/l

29.92

11732

106362

(3018851) Theophylline [Moles/volume] in Serum or Plasma

126

3.44

13.21

1.6

1.7

49.80

49.02

umol/l

0.05

126

(3032352) Blasts [#/volume] in Cerebral spinal fluid

140

3.30

13.19

2.1

2.2

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2622

21371

1.18

13.17

1.3

12.40

13.41

u/ml

0.28

916

8027

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

223

1224

1.72

13.15

1.6

1.3

32.27

30.99

u/l

0.19

181

1008

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

416

2655

1.49

13.04

1.3

1.2

50.14

46.39

u/ml

0.15

246

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

4.44

12.98

1.0

1.1

1.33

0.97

u/field

1.41

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

112

492

2.15

12.87

1.1

309.99

188.35

iu/ml

1.18

112

487

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

224

1239

1.71

12.86

1.7

1.4

0.25

0.31

nmol/l

0.89

164

876

(3001686) Cold agglutinin [Titer] in Serum or Plasma

251

2.63

12.65

1.3

1.4

40.57

530.61

titre

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1381

10624

1.24

12.58

1.6

1.5

—

(3006270) Folate [Moles/volume] in Blood

200

1080

1.75

12.52

1.2

331.83

339.29

nmol/l

0.17

153

886

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

210

2.79

12.50

1.7

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

210

2.79

12.50

2.6

3.1

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

232

2.68

12.41

1.6

1.5

112.50

110.14

ug/l

0.06

192

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

149

737

1.91

12.38

1.1

7.59

8.29

nmol/l

0.06

146

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

104

455

2.16

12.11

1.1

29.38

12.39

u/ml

0.51

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.71

11.89

1.2

—

(3013336) Amino acids [Identifier] in Serum or Plasma

13.46

11.80

6.3

2.4

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

384

2473

1.47

11.56

1.3

179.71

212.19

miu/ml

0.62

1043

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

5.82

11.49

1.1

1.0

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

4.12

11.47

1.1

7930.50

3381.14

ng/l

0.50

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

356

2.28

11.47

2.0

2.9

1.88

1.94

ratio

0.12

322

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

200

1109

1.71

11.44

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

300

2.39

11.29

2.0

2.4

0.15

0.74

e9/l

1.28

157

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

135

3.14

11.25

2.6

3.2

1.59

1.33

mg/l

0.36

(3039162) Centromere protein B Ab [Units/volume] in Serum

256

1534

1.58

10.81

1.3

51.07

64.29

u/ml

0.33

100

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

9.90

10.78

7.6

4.0

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

120

580

1.95

10.74

2.2

2.0

37.61

40.19

g/l

3.76

120

580

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

171

925

1.75

10.72

1.3

1.4

1.22

1.78

u/ml

0.49

559

(3019420) Tryptase [Mass/volume] in Serum or Plasma

131

653

1.90

10.71

1.2

1.6

9.99

9.49

ug/l

0.12

115

600

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

141

720

1.85

10.70

1.2

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

350

2.24

10.63

1.1

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

176

963

1.73

10.60

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

245

1464

1.58

10.48

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

178

2.76

10.35

1.1

1.0

—

(3038026) Centromere Ab [Units/volume] in Serum

195

1105

1.67

10.34

1.3

1.2

27.92

50.68

u/ml

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

3659

38048

0.88

10.31

4.4

4.8

22.06

21.91

0.21

1853

20087

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

158

2.87

10.27

4.1

2.4

0.60

0.56

u/field

0.11

158

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

302

2.31

10.25

2.1

2.3

7.19

7.28

mmol/l

0.07

186

(3001964) Herpes simplex virus Ag [Presence] in Specimen

320

2.27

10.23

1.6

1.3

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

237

1414

1.59

10.22

1.5

1.4

68865.50

138279.25

e6/l

1.13

161

954

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

245

2.46

10.20

1.8

1.5

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

240

2.48

10.15

2.6

2.8

2686.60

1486.89

u/l

0.33

218

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

437

2957

1.40

10.12

1.2

1.1

3.36

3.82

0.30

306

(3023511) Choriogonadotropin [Units/volume] in Urine

169

927

1.72

10.11

1.6

1.3

—

(4146454) Self-monitoring of blood glucose

249

1507

1.56

10.10

3.0

2.6

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

181

2.71

10.04

1.1

1.0

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

527

3682

1.36

10.04

1.6

1.4

28.62

31.55

iu/l

1.08

438

3153

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

156

2.84

9.92

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

171

950

1.70

9.79

1.2

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

4.28

9.76

1.3

1.6

1.38

1.62

mg/l

0.12

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

4.28

9.76

1.3

1.6

0.34

2.22

mg/l

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

4.28

9.76

1.3

1.6

2.02

3.78

mg/l

0.75

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

4.28

9.76

1.3

1.6

1.98

2.27

mg/l

0.09

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

4.28

9.76

1.3

1.6

2.42

2.16

mg/l

0.08

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

4.28

9.76

1.3

1.6

0.88

1.46

mg/l

0.30

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

4.28

9.76

1.3

1.6

4.69

3.18

mg/l

0.37

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

4.28

9.76

1.3

1.6

1.24

2.04

mg/l

0.51

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

4.28

9.76

1.3

1.6

0.63

1.55

mg/l

0.66

(3020491) Glucose [Moles/volume] in Blood

163

898

1.72

9.63

1.8

1.9

7.71

6.96

mmol/l

1.51

113

620

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

4.52

9.58

1.1

1.3

0.32

0.64

iu/ml

0.59

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

3.67

9.56

1.2

1.1

50.91

51.37

u/l

0.01

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

219

2.50

9.55

1.2

82.88

77.42

0.29

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

4.13

9.34

1.3

1.6

2.00

1.64

mg/l

0.11

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2182

17994

1.16

9.26

15.9

7.0

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

166

931

1.69

9.21

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

161

897

1.70

9.15

1.2

—

(3033086) Enterovirus Ab [Titer] in Serum

7.33

9.15

1.0

—

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

3.48

9.14

1.6

1.2

0.77

1.14

ml/s/173m2

1.06

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

4.19

9.12

1.7

1.3

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

217

1305

1.57

9.11

1.2

77.06

79.71

u/ml

0.06

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1119

8713

1.22

9.10

2.4

2.5

17.52

22.63

au/ml

1.23

836

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

295

2.24

9.05

14.4

6.5

5.66

5.97

kpa

1.98

253

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

165

930

1.68

8.99

1.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

279

2.27

8.92

2.0

1.9

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

109

546

1.89

8.87

1.2

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

100

3.21

8.85

3.6

2.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

183

1065

1.62

8.82

1.5

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

462

1.96

8.79

1.1

—

(3026480) Teichoate Ab [Titer] in Serum

120

2.99

8.79

1.1

—

2.29

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1033

8017

1.23

8.68

1.2

1.3

60.34

58.08

au/ml

0.07

553

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

283

2.23

8.63

1.1

991.67

839.06

titre

0.38

(3018333) Ribosomal P Ab [Presence] in Serum

156

877

1.68

8.61

1.2

—

(40763791) Oxygen content in Venous blood by calculation

4.84

8.58

2.3

5.4

12.65

11.66

ml/dl

0.42

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

3.97

8.52

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

220

2.40

8.52

1.2

68.95

72.51

0.21

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

118

616

1.81

8.45

1.2

1.1

1.08

1.07

ratio

0.35

103

495

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

118

2.96

8.43

1.1

1.0

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

124

2000

0.58

8.41

1.6

1030.92

1013.99

mu/l

0.08

101

1648

(3007463) Buprenorphine [Presence] in Urine

8.90

8.39

3.9

11.6

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

159

907

1.66

8.32

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

324

2.10

7.96

1.2

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

3.38

7.95

1.0

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

199

2.42

7.90

1.4

1.3

97.75

537.50

ng/l

0.57

137

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

488

1.88

7.84

1.1

1.0

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

3.50

7.77

1.2

1.0

1.76

3.76

u/l

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

284

2.16

7.76

1.2

1.1

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

3.39

7.71

2.4

2.5

189.43

42.46

pmol/l

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

9.42

7.69

1.5

1.41

2.44

g/l

1.60

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

130

2.76

7.66

1.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

122

2.78

7.40

1.1

1.0

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

253

2.20

7.39

15.4

6.2

6.24

5.33

kpa

1.53

253

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

160

2.53

7.38

1.1

—

(3002256) Pathology report gross observation

2205

18489

1.14

7.33

1.4

1.3

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

238

1534

1.47

7.32

4.3

4.1

99.30

58.69

u/ml

0.95

231

1504

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

3.77

7.32

1.7

1.4

1.25

1.13

u/field

0.33

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

113

611

1.75

7.26

2.2

157.13

59.75

ug/min

0.92

128

(3044009) aPTT.lupus sensitive (LA screen)

3.18

7.24

1.2

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

111

2.80

6.90

1.1

1.2

—

(3033942) Copper [Moles/time] in 24 hour Urine

4.33

6.76

1.1

1.0

0.16

0.34

umol/24h

—

(3024263) Appearance of Synovial fluid

123

698

1.66

6.67

1.9

1.6

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

374

1.92

6.64

1.2

—

(4212803) Bone marrow aspirate examination

103

2.84

6.64

1.1

1.0

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

348

1.95

6.63

2.2

1.8

19.23

52.83

u/l

2.70

322

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

181

2.34

6.59

1.2

1.3

42.94

50.66

0.38

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

170

2.38

6.54

1.1

1.2

—

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

248

2.13

6.53

1.0

1.1

—

21.09

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

364

1.92

6.48

5.4

6.8

64.38

71.22

1.01

281

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.97

6.48

2.4

2.9

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

3.23

6.40

1.4

1.2

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

3.94

6.38

1.9

5.0

16.30

12.72

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

161

2.40

6.34

13.2

8.9

0.35

0.46

umol/l

0.33

146

(3016273) Islet cell 512 Ab [Units/volume] in Serum

3.62

6.32

1.0

—

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

101

2.80

6.29

1.3

1.1

29.67

24.19

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

3.47

6.24

1.6

1.7

441.05

521.75

nmol/l

0.25

(3051387) C reactive protein [Mass/volume] in Capillary blood

383

2750

1.32

6.24

5.1

3.3

28.41

29.30

mg/l

0.20

294

1881

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

390

1.86

6.19

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

390

1.86

6.19

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

390

1.86

6.19

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

390

1.86

6.19

1.2

1.1

—

(37208534) Antinuclear antibody arbitrary concentration in serum

351

1.91

6.15

1.0

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

226

2.13

5.97

1.0

1.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

13779

127250

1.11

5.88

6.6

5.7

2.34

2.70

mmol/l

307.65

12618

116135

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

140

848

1.56

5.87

4.3

4.9

137.36

147.34

u/ml

0.05

267

(3049233) Organic acids panel - Urine

11.77

5.85

1.2

1.0

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

208

1368

1.44

5.85

1.1

3.86

3.91

eliau/ml

0.01

532

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

344

1.89

5.85

1.6

1.7

10.85

9.26

ug/l

1.18

344

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

106

602

1.66

5.79

1.2

—

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

2.83

5.78

1.1

1.4

43.14

38.08

0.18

(3019174) dRVVT (LA screen)

2.94

5.75

1.2

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

202

1328

1.44

5.71

2.0

1.8

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

3.24

5.66

1.1

1.4

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

365

2643

1.31

5.64

1.6

1.4

299.63

178.92

pmol/l

1.57

350

2584

(4034850) Laboratory test

555

4234

1.24

5.60

15.9

11.2

—

(3000285) Sodium [Moles/volume] in Blood

278

1.97

5.54

1.5

1.2

133.65

138.55

mmol/l

4.91

229

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

103

2.65

5.54

1.3

1.2

23.57

20.74

nmol/l

—

(3021367) Citalopram [Moles/volume] in Serum or Plasma

5.44

5.52

1.3

1.4

174.20

112.56

nmol/l

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

258

1786

1.37

5.42

1.3

1.2

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

144

2.36

5.40

1.1

1.2

132.66

100.88

ug/l

0.56

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

5408

53718

0.92

5.39

2.2

1.9

1.41

1.30

mmol/l

12.52

4426

43553

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

962

0.53

5.37

1.4

1.6

—

(3032641) Amino acids panel - Urine

15.07

5.23

1.6

1.0

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1166

0.58

5.15

1.5

61.34

59.89

ug/l

0.11

967

(3013166) Neutrophils/Leukocytes in Synovial fluid

426

1.73

4.98

1.5

1.3

69.44

55.32

2.93

363

(3034426) Prothrombin time (PT)

325

1.83

4.88

1.3

1.2

27.83

28.44

0.34

325

(3050129) First trimester maternal screen panel - Serum or Plasma

1342

0.62

4.80

1.5

1.4

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

183

2.11

4.79

1.2

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

183

2.11

4.79

1.2

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

183

2.11

4.79

1.2

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

3.09

4.76

1.3

1.6

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

935

0.55

4.73

1.7

1.6

—

(44806420) Estimation of glomerular filtration rate

174

1156

1.42

4.72

3.0

2.5

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

148

2.23

4.67

2.0

1.8

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

114

2.40

4.56

6.1

4.8

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

910

0.56

4.52

1.6

1.5

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

737

5910

1.18

4.52

1.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

507

1.62

4.40

2.6

2.2

22.68

264.67

ug/l

1.16

479

(40762887) Creatinine [Moles/volume] in Blood

122

2.32

4.39

1.5

1.4

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

309

3700

0.78

4.37

2.3

1.7

5.34

4.64

mg/l

0.47

261

2723

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

150

986

1.44

4.35

1.0

481.59

354.44

ng/l

0.23

111

663

(4015189) Microbial culture of sputum

415

1.68

4.35

2.3

2.4

—

(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma

9.42

4.34

4.3

1.3

22.60

30.13

umol/l

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

150

988

1.43

4.31

1.0

760.61

716.69

ng/l

0.51

104

640

(3005033) Fetal Nuchal fold Thickness US

894

0.57

4.27

1.6

1.5

1.30

1.28

0.15

633

(3013139) Helicobacter pylori Ag [Presence] in Stool

1061

8792

1.15

4.25

1.2

1.3

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

13488

124872

1.08

4.23

5.9

5.1

4.26

4.63

mmol/l

281.89

12372

114608

(3002619) Bacteria identified in Specimen by Culture

383

1.70

4.22

1.4

1.3

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

150

993

1.43

4.20

1.0

30.84

45.01

ng/l

6.89

108

658

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1087

0.61

4.15

1.5

1.11

1.12

ratio

0.05

665

(40768800) Prostate Pathology biopsy report

269

3253

0.77

4.14

1.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.67

4.13

1.0

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1074

0.61

4.13

1.5

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.87

4.03

1.8

1.3

351.56

343.81

umol/24h

0.05

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1088

0.62

4.00

1.5

0.93

0.95

ratio

0.29

666

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1088

0.62

4.00

1.5

1.15

1.18

ratio

0.14

668

(3023436) Glucagon [Mass/volume] in Serum or Plasma

2.69

3.99

1.9

1.4

275.50

194.33

ng/l

0.48

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

205

1.93

3.92

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

135

2.16

3.91

2.3

2.4

0.69

0.65

ug/l

0.28

135

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1586

16430

0.90

3.89

1.5

1.4

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

3.07

3.76

1.5

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

426

1.62

3.74

1.0

99.37

95.37

0.51

336

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

189

1.94

3.73

7.6

6.5

9.92

10.42

0.76

189

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

715

0.55

3.72

1.5

67.14

59.55

ug/l

0.32

715

(3036670) Protein [Mass/volume] in Synovial fluid

465

1.58

3.67

1.3

39.57

39.66

g/l

0.02

240

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.63

3.65

1.0

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

5.65

3.63

1.0

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.47

3.58

1.1

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.76

3.57

1.1

223.88

290.17

nmol/l

1.17

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

240

1764

1.28

3.48

1.1

27.35

16.84

au/ml

0.41

353

(3044416) Complement C4 [Mass/volume] in Pleural fluid

2.56

3.47

1.3

0.06

0.08

g/l

0.52

(3050794) Legionella sp Ab [Presence] in Serum

105

2.24

3.46

1.0

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

840

0.60

3.44

1.4

99.35

176.48

pmol/l

4.45

840

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.36

3.40

1.1

7.00

11.91

u/l

0.81

(3045683) HLA typing for celiac disease panel - Blood or Tissue

588

1.49

3.39

1.0

—

(3036180) Methadone [Presence] in Urine

5.80

3.33

2.5

2.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

850

0.62

3.25

1.6

1.8

—

(3022640) Eosinophils/Leukocytes in Cerebral spinal fluid

2.58

3.18

1.1

1.3

1.18

1.35

0.06

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.33

3.18

1.1

1.0

0.04

0.03

u/ml

0.33

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

141

2.00

3.17

1.1

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

8.07

3.13

1.0

1.3

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

8.07

3.13

1.0

1.3

—

(3028468) Fragments [Presence] in Blood by Light microscopy

8.07

3.13

1.0

1.4

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.54

3.09

1.4

1.6

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

111

2.12

3.06

1.3

2.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

548

1.48

3.05

6.0

6.7

36.95

183.52

ug/l

1.41

345

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.50

3.00

1.3

1.2

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

3.57

2.98

1.0

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

7.06

2.92

1.2

1.0

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

3.77

2.89

1.2

1.1

—

(3037577) Monocytes/Leukocytes in Cerebral spinal fluid

2.32

2.89

1.1

1.4

28.69

10.97

1.05

(3035611) Eosinophils/Leukocytes in Synovial fluid

2.27

2.88

1.7

1.8

0.61

0.76

0.21

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

13339

123898

1.07

2.81

5.8

5.0

1.44

1.48

mmol/l

24.00

12163

112849

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

2.78

2.80

1.0

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

812

6816

1.13

2.77

1.9

—

(3034092) Cytoplasmic Ig cells/cells in Blood

136

1.94

2.74

26.5

6.4

0.27

0.22

0.45

136

(3032333) Phosphate [Mass or Moles] in 24 hour Urine

5.07

2.73

1.0

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

5.07

2.73

1.7

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

152

1094

1.31

2.68

3.8

2.6

28.75

31.79

mg/l

0.49

123

801

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

292

1.61

2.66

2.6

2.7

127.19

145.64

au/ml

0.15

(40768795) Lymph node Pathology biopsy report

196

1461

1.27

2.64

1.3

1.2

—

(3011325) HIV 1+2 Ab [Presence] in Serum

2.66

2.60

1.0

0.08

0.21

(4094501) Cardiovascular stress test using bicycle ergometer

301

3396

0.83

2.59

1.1

—

(3001729) Color of Synovial fluid

100

2.07

2.58

1.6

1.7

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

208

1.72

2.58

1.1

1.4

30.46

44.37

mg/l

1.10

181

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1251

12832

0.91

2.58

1.5

1.6

—

6.09

—

(3035082) Kappa light chains [Mass/volume] in Urine

2.54

2.56

1.1

0.08

0.24

g/l

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

318

1.57

2.54

3.1

3.8

6.61

8.24

mg/l

1.25

260

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.12

2.48

1.0

1.1

—

(1002224) Polysomnography panel

416

4546

0.86

2.47

1.1

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

183

1.75

2.46

1.6

—

(3018291) Platelet Ab [Presence] in Serum

3.77

2.41

1.4

1.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

265

0.43

2.40

1.7

1.5

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

205

1561

1.24

2.34

1.1

3.00

3.21

0.07

184

(3027874) Urate [Moles/volume] in Urine

2.50

2.32

1.0

1.2

1.84

1.51

mmol/l

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

320

3550

0.85

2.32

1.4

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

3.59

2.31

1.3

1.1

190.76

300.76

u/ml

—

(40758292) HTLV I+II Ab panel - Serum

231

1.63

2.27

1.4

1.3

—

(3006462) Nitrate [Presence] in Urine

664

1.36

2.26

5.4

3.5

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

119

1.90

2.26

1.0

1.1

21.64

19.39

iu/ml

0.08

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.73

2.23

1.0

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

3.88

2.22

1.7

3.3

5.36

2.26

mu/l

—

(3012989) Citrate [Moles/time] in 24 hour Urine

4.35

2.15

1.8

1.3

1.58

2.02

mmol/24h

—

(3020618) Glucose [Moles/volume] in Synovial fluid

2.31

2.15

1.0

4.84

4.92

mmol/l

—

(3012403) Metanephrines [Moles/time] in 24 hour Urine

3.66

2.12

1.3

1.1

—

25.24

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

341

1.49

2.11

1.8

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

274

2177

1.19

2.07

4.2

3.9

48.97

47.63

u/ml

0.04

264

2112

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.69

2.04

1.1

1.0

0.02

0.04

u/ml

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

352

1.47

2.03

1.5

1.3

24.16

37.30

2.24

238

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

522

0.63

2.02

1.2

1.3

—

(4211845) Urine protein measurement

101

719

1.32

2.01

5.4

3.4

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.31

2.00

1.3

1.0

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

160

1.71

1.98

1.1

1.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

146

1.74

1.97

1.6

—

(44806071) Cardiolipin IgM antibody measurement

146

1.74

1.97

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

2.09

1.97

1.3

1.1

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

248

1.56

1.96

1.1

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

3.30

1.93

1.0

1.1

41.14

37.39

mg/24h

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.65

1.85

1.4

41.21

75.83

umol/24h

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.65

1.85

1.6

1.1

—

(3001218) Citrate [Mass/time] in 24 hour Urine

4.28

1.84

2.0

1.5

229.40

531.00

mg/24h

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

115

1.80

1.81

1.7

1.6

—

(3034614) HLA Ag [Interpretation]

3.00

1.75

1.3

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

3.32

1.73

1.0

—

(3024316) Viscosity of Plasma

2.15

1.72

1.2

2.4

1.63

1.61

mpas

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.22

1.70

1.2

1.5

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

108

798

1.28

1.69

1.5

—

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

1160

0.78

1.69

9.5

2.6

13.81

13.22

3.59

1143

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

865

7509

1.09

1.66

1.9

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.86

1.65

3.0

5.3

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

112

1.77

1.64

1.0

0.01

0.62

u/ml

0.94

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

2.17

1.64

44.6

5.2

100.92

106.71

g/l

1.48

(3036071) Salmonella sp Ab [Titer] in Serum

322

1.43

1.64

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

329

3526

0.88

1.61

2.0

1.8

47.54

43.90

nmol/l

1.56

319

3415

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

2.20

1.55

1.7

1.5

0.00

0.20

u/l

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

271

1.46

1.55

1.4

1.2

0.77

74.91

mg/l

1.47

201

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.64

1.53

1.0

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

2.01

1.48

1.0

7935.38

9835.88

ng/l

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

128

0.44

1.40

3.5

3.0

28.00

43.40

—

128

(3032868) Hemoglobin electrophoresis panel in Blood

1.78

1.39

1.7

1.5

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

2.07

1.36

1.1

1.0

0.02

0.11

u/ml

—

(3051101) Glucose [Moles/volume] in Cord blood

225

1.47

1.35

5.9

5.5

8.87

8.46

mmol/l

0.39

225

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

361

0.65

1.34

1.9

1.7

1.90

2.79

u/ml

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

267

1.41

1.28

1.3

1.2

—

(44813793) Dust mix specific IgE antibody measurement

112

864

1.22

1.28

1.1

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

127

0.44

1.27

7.0

5.9

11.17

8.15

—

127

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

682

1.24

1.22

1.5

1.6

2.52

4.56

ug/l

1.60

536

(3010726) Horse dander IgE Ab [Units/volume] in Serum

142

1580

0.84

1.22

1.2

1.1

0.83

1.23

u/ml

0.60

792

(4038314) Semen analysis, post vasectomy

2.35

1.20

1.5

1.3

—

(3028714) Urate [Moles/time] in 24 hour Urine

2.62

1.20

1.2

1.1

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

147

1.54

1.18

1.2

1.1

3.69

9.11

u/ml

0.51

102

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

103

796

1.22

1.18

1.2

—

(3009871) Measles virus Ab [Titer] in Serum

410

1.31

1.18

1.6

4800.00

3272.82

titre

0.79

(3014133) Dog dander IgE Ab [Units/volume] in Serum

122

1370

0.84

1.17

1.1

2.70

3.29

u/ml

0.27

661

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

376

3203

1.11

1.17

1.9

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

104

1183

0.83

1.15

1.1

0.09

0.24

u/ml

2.16

399

(3007919) Fasciola sp Ab [Titer] in Serum

2.48

1.13

1.2

1.0

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

136

1.52

1.06

1.4

1.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

1.68

1.05

1.0

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

262

2749

0.90

1.01

2.2

1.8

180.98

204.16

pmol/l

2.83

234

2596

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

240

1.37

1.01

1.7

3.2

150.08

130.91

ng/l

0.14

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

2.24

1.01

2.6

2.0

252.76

215.59

ug/l

—

(40765096) Chromosome analysis panel by Banding

464

1.26

0.99

1.2

1.1

—

(3020650) Glucose [Presence] in Urine

481

1.25

0.98

2.0

1.6

0.05

0.03

estimate

0.17

481

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

634

1.22

0.98

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1988

18066

1.04

0.94

5.4

4.9

34.45

32.83

7.41

1400

11570

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

2.26

0.94

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

196

1.39

0.93

1.0

1.1

17.92

35.32

iu/ml

2.23

196

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

445

3878

1.08

0.91

2.1

2.0

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

111

1.53

0.90

1.3

21.25

21.35

mmol/l

0.01

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

166

1.42

0.89

1.4

1.5

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

786

1.17

0.83

1.1

9.73

8.79

iu/ml

0.15

181

(3041672) Baker's yeast Ab [Presence] in Serum

1.70

0.82

1.0

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

124

1337

0.87

0.80

1.2

8.41

7.53

mmol/l

2.40

108

1146

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.79

0.0

1.0

—

1.24

—

(42528597) U1 small nuclear ribonucleoprotein C Ab [Presence] in Serum by Line blot

1.82

0.79

1.0

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

1.82

0.79

1.0

—

(3033099) Centromere Ab [Titer] in Serum

347

1.25

0.74

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

255

1.29

0.73

1.1

0.76

4.77

u/ml

0.61

133

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.78

0.72

1.0

8.28

0.28

u/ml

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

248

0.72

0.69

1.8

1.4

16.19

32.83

nmol/l

2.47

217

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

513

1.19

0.69

1.2

1.3

6.43

6.00

mmol/l

1.25

484

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.57

0.64

1.0

1.1

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

220

0.73

0.61

1.2

53.69

69.47

u/ml

0.47

214

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

1.45

0.59

1.6

1.7

—

(1617658) Protocol used for examination of sentinel lymph nodes

1012

0.88

0.57

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

269

2721

0.93

0.57

1.4

1.5

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

122

1279

0.90

0.56

1.1

3.34

3.86

u/ml

0.14

554

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

126

1.35

0.52

1.1

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.53

0.52

1.0

1.1

—

(3022475) Manganese [Moles/volume] in Blood

1.46

0.49

1.2

1.3

0.17

0.16

umol/l

0.23

(3008401) Mugwort IgE Ab [Units/volume] in Serum

164

1677

0.92

0.48

1.1

1.31

0.77

u/ml

0.32

752

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

518

0.85

0.48

1.1

1.2

—

(46235168) Fasting glucose [Moles/volume] in Blood

146

1.29

0.46

2.0

1.8

8.42

7.15

mmol/l

0.79

(3025018) Bordetella pertussis Ab [Titer] in Serum

732

1.12

0.46

1.2

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

259

1.20

0.43

2.2

1.6

2.75

2.22

ug/l

0.34

143

(3003888) Timothy IgE Ab [Units/volume] in Serum

171

1731

0.93

0.42

1.1

2.57

3.96

u/ml

1.12

899

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.41

0.0

1.1

—

0.45

—

(3009883) Potato IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.01

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.40

0.41

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

183

1.24

0.41

1.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.40

0.0

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

4973

47318

0.98

0.40

5.3

5.8

3.41

3.67

ug/l

0.36

4404

42537

(3009015) Lactate [Moles/volume] in Synovial fluid

175

1.24

0.40

1.4

1.2

6.55

6.71

mmol/l

0.06

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.68

0.39

1.3

1.2

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.39

0.0

6.5

—

0.21

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.32

0.37

1.3

1.1

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

126

1.27

0.36

1.1

84.61

79.49

ug/l

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

118

1.28

0.36

1.1

1.2

6.28

6.17

mmol/l

0.23

118

(3025577) Chromium [Mass/volume] in Blood

994

0.92

0.34

2.2

2.1

2.18

2.40

ug/l

0.23

827

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

441

0.87

0.34

1.3

14.05

11.07

mm/h

0.61

441

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

111

1.27

0.33

1.1

83.20

93.98

titre

0.41

111

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.70

0.33

1.3

1.1

—

(40768793) Breast Pathology biopsy report

353

3188

1.04

0.33

1.4

1.3

—

(4133840) Spirometry

312

1.15

0.32

1.4

1.2

—

(40763590) HLA-DQ beta [Type]

1.35

0.31

1.0

—

(46236302) HLA-C [Type] by High resolution typing

1.32

0.30

1.0

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

1.29

0.30

1.3

1.2

7.09

0.84

u/ml

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.24

0.29

1.4

1.0

—

(3001556) Androgen free Index in Serum or Plasma

1.24

0.29

1.1

1.3

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

342

1.13

0.29

2.2

2.0

8.05

9.20

mg/l

0.83

277

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

641

0.91

0.28

1.1

35.18

20.08

u/ml

0.86

234

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

204

2016

0.95

0.28

1.1

1.89

1.92

u/ml

0.01

106

1108

(3041806) Other cells [#/volume] in Blood by Manual count

132

1.21

0.27

1.9

1.6

0.59

0.50

e9/l

0.53

132

(40758358) Immune stain study

1.21

0.26

1.0

—

(3020874) Milk IgE Ab [Units/volume] in Serum

549

0.91

0.26

1.1

0.54

1.98

u/ml

1.35

171

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

617

1.08

0.25

5.4

4.4

42.82

9620.69

u/ml

0.52

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

152

1.18

0.23

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

298

0.88

0.22

1.1

1.0

8.84

10.77

u/ml

0.21

173

(3002523) Influenza virus A Ag [Presence] in Specimen

183

1649

1.05

0.22

1.1

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

1.18

0.21

1.0

1.2

—

(3012932) Hazelnut IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

15.58

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

1.23

0.20

1.0

0.06

4.85

u/ml

—

(3010937) Rubella virus Ab [Presence] in Serum

1.13

0.18

1.0

1.1

—

(40760410) HLA-B [Type] by High resolution

1.13

0.18

1.0

—

(40760409) HLA-A [Type] by High resolution

1.13

0.18

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.22

0.18

1.0

—

(3026470) Cobalt [Mass/volume] in Blood

104

1028

0.95

0.17

2.1

2.2

3.88

3.83

ug/l

0.02

955

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

364

1.09

0.17

1.3

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

182

1653

1.04

0.17

1.1

—

(42870560) Thyrotropin [Units/volume] in Cord blood

1.14

0.17

1.0

16.13

7.05

mu/l

—

(3008898) HLA-B27 [Presence]

349

3366

0.98

0.16

1.1

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.16

0.16

12.4

9.4

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1132

10790

0.99

0.16

2.7

2.2

10.94

13.16

nmol/l

13.93

947

9646

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.10

0.15

1.0

1.1

—

(3025130) Human papilloma virus identified in Specimen

149

1355

1.04

0.14

1.7

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

539

0.94

0.13

1.1

3.94

1.39

u/ml

0.56

134

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

323

0.93

0.11

3.3

1.7

17.68

274.88

pmol/l

0.60

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

10900

102443

1.00

0.11

50.7

21.0

331.50

331.77

g/l

1.94

10841

101740

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

1.12

0.10

1.0

1.1

—

(3006598) pH of Arterial cord blood

1.05

0.09

1.0

—

(40762814) Titanium [Mass/volume] in Blood

302

1.06

0.09

2.0

2.5

3.40

3.58

ug/l

0.13

116

(3013862) HLA-DP [Type]

1.09

0.08

1.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.03

0.08

1.1

0.97

0.22

u/ml

—

(3029396) Erythrocyte agglutination [Presence] in Blood

149

1.07

0.05

1.6

2.8

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

446

0.97

0.04

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

559

0.98

0.04

1.1

10.42

6.47

u/ml

0.45

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

102

0.92

0.03

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

119

1.03

0.00

1.3

2.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.97

0.00

1.8

2.8

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

471

1.00

0.00

1.1

0.28

2.36

u/ml

0.87

119

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

-0.00

0.0

1.8

—

(3028050) Streptolysin O Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

149.40

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3026820) Hemoglobin [Mass/volume] in Venous cord blood

0.00

-0.00

0.0

1.0

—

160.80

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

-0.00

0.0

7.0

—

(3015057) Respiratory syncytial virus Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.94

-0.00

1.3

1.1

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

-0.00

0.0

1.0

—

15.41

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint E4_FLUIDELECTRO and mortality.

Females

Parameter	HR [95% CI]	p-value
E4_FLUIDELECTRO	2.069 [1.88, 2.28]	< 0.001
Birth year	0.993 [0.99, 1.0]	0.075

During the follow-up period (1.1.1998 — 31.12.2019), 30904 out of 62802 females with E4_FLUIDELECTRO died.

Males

Parameter	HR [95% CI]	p-value
E4_FLUIDELECTRO	3.843 [3.36, 4.4]	< 0.001
Birth year	0.985 [0.98, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 19521 out of 38323 males with E4_FLUIDELECTRO died.

Mortality risk

Mortality risk for people of age

years, who have E4_FLUIDELECTRO.

N-year risk	Females	Males
1	0.214%	0.689%
5	1.134%	4.028%
10	2.629%	9.432%
15	5.084%	16.832%
20	8.733%	27.242%

Relationships between endpoints

↥

Index endpoint: E4_FLUIDELECTRO – Other disorders of fluid, electrolyte and acid-base balance

GWS hits: 3

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other disorders of fluid, electrolyte and acid-base balance

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints